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Abstract
Medication education by nurses during patients’ hospital stay is an important component
of patient care. Nurses’ knowledge of specific medications and the resources that support
teaching patients about medications may play a key role in increasing their satisfaction
with the hospitalization experience. This quality improvement doctoral project created
and validated evidenced-based cognitive aids for nurses to support this process. The
project is part of a quality improvement initiative at a hospital in South Jersey to create
and validate cognitive aids for 5 high frequency medications prescribed for patients prior
to discharge from the hospital The cognitive aids focused on three areas of medication
teaching: how the medications work, why the medications are being prescribed, and the
medications’ side effects. Each aid included the teach-back method. Interprofessional
content experts established content validity by reviews of draft cognitive aids on
medication content and the teach-back process. The Flesch-Kinkaid Grade level was
calculated on revised cognitive aids. Improvement of nursing communication scores on
medication survey items of the Hospital Consumer Assessment of Healthcare Providers
and Systems survey will be evaluated after the quality improvement project has been
implemented.
Keywords: medication cognitive aid, discharge, HCAHPS medication education, patient
satisfaction.
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Improving Medication Education for Hospitalized Patients at Discharge:
A Quality Improvement Project
The Affordable Care Act (ACA) signed into law in March of 2010 was designed
to provide affordable healthcare coverage for all Americans and protect consumers from
the rising cost of healthcare. Because of the ACA, the Centers for Medicare and
Medicaid Services (CMS) introduced the Value Based Purchasing (VBP) Program, which
started in 2013. Under this program, Medicare makes incentive payments to acute care
hospitals based on their performance in patient experience, clinical process of care, and
outcomes (CMS, 2020). Also, the enactment of the Deficit Reduction Act in 2005 created
an incentive for hospitals to participate in Hospital Consumer Assessment of Healthcare
Providers and Systems Surveys (HCAHPS). As of July 2007, hospitals subject to the
Inpatient Prospective Payment System (IPPS) were required to collect and submit
HCAHPS data to receive their full annual payment (Price, 2019).
The VBP program incentivizes hospitals with payments based on the quality, not
quantity, of the care provided to the patients (CMS, 2021). VBP is funded by reducing
the participating hospital’s base operating Medicare severity diagnosis-related group
(MS-DRG) payments by 2% (CMS, 2021). The hospital is evaluated for performance in 4
categories: (a) clinical outcomes; (b) person and community engagement as measured by
(HCAHPS scores); (c) safety; and (d) efficiency and cost reduction (CMS, 2021). It is in
the best interest of the hospital to perform well in those domains to earn back or receive
more than the 2% withheld.
Virtua Health (VH) is one of New Jersey’s largest health systems. VH employs
over 14,000 colleagues to serve the health care needs of persons living or working in

2

South Jersey. As a Magnet®-recognized health system, VH is recognized for its
continued initiatives to address and improve the quality, safety, and work environment
for employees and patients (Virtua Health, 2021). VH carries out many quality
improvement initiatives to improve patient care. Leaders have targeted patient education
on medication knowledge as an important quality improvement target.
Problem Statement
VH strives to provide the best care to patients and to achieve higher than national
average on HCAHPS. One 2021 global nursing goal was to improve nurses’
communication about medications on HCAHPS items. For example, leaders aim to
increase the score on nursing communication about medications from 56.4% in 2020 to
62.1% in 2021. In 2021, the hospital system finished the year with a 56.9% score, not
meeting the goal of 62.1%. Continued efforts to improve the scores are ongoing,
however, more targeted interventions to improve the scores are needed. Year to date in
2022, the hospital system has been below the benchmark for: staff described medication
side effects (41.6%, benchmark 50%), told what the medicine was for (73.5%, benchmark
76%), and nurses explained things understandably (75.6%, benchmark 76%).
VH’s Mount Holly Hospital’s 36-bed infectious disease unit (IDU) has scored
lower than the benchmark of the CMS 50th percentile over the past several years, when
compared to like hospitals, on three HCAHPS questions related to patient education. The
questions are:
•

During the hospital stay, how often did nurses explain things in a way you
could understand?
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•

Before giving you any new medicine, how often did the hospital staff tell
you what the medicine was for?

•

Before giving you any new medicine, how often did hospital staff
describe possible side effects in a way you could understand?

Year to date, the unit HCAHPS scores for these items are: 28.6% for staff
described medication side effects (benchmark of 46.5%), 71.4% for told what the
medicine was for (benchmark of 78%), and 53.5% for nurses explained things
understandably (benchmark of 74.4%). The findings provide the needs assessment for
this Doctor of Nursing Practice (DNP) project.
Although patient satisfaction scores are important and play a vital role in hospital
payment, failure to provide adequate patient education to patients during hospitalization
also has a direct link to 30-day readmissions and adverse events. Of note is that certain
diagnoses will not be reimbursed by CMS for treatment if a patient is readmitted within
30 days of discharge. A study by the Agency for Health Care Research and Quality
(AHRQ) in 2016 found that 1 in 5 patients experienced an adverse event within 3 weeks
of discharge. The most common adverse event was directly related to medications
(Agency for Healthcare Research and Quality 2019). National and regional organizations
intent on improving health care safety for patients support the need for adequate, concise,
understandable medication education when a patient is hospitalized to avoid adverse
events related to medications and to promote optimal healing.
In summary, patient satisfaction scores are a priority at VH due to their impact on
reimbursement. Readmission rates are another priority, especially when associated with
patients’ lack of knowledge regarding how the medications work, why the medications
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are being prescribed, and the medications’ side effects. Therefore, patients’ medication
knowledge is a priority for not only the IDU at VH’s Mount Holly campus, but also the
entire hospital system.
Purpose
The purpose of this quality improvement project was to create and validate
cognitive aids for high frequency prescribed medications to be used with the process of
teach-back method. The project addressed the gap in practice related to nurse
communication about medications as evidenced by low HCAHPS scores for the IDU.
This doctoral project developed evidence-based cognitive aids for nurses to teach patients
about high frequency, newly prescribed medications. The cognitive aids may assist in
educating patients on newly prescribed, first dose medications while hospitalized. Having
an evidence-based education process in place for the nurses to utilize may not only
increase patient knowledge, but also increase patients’ perception of their care, or
satisfaction, while in the hospital and as reported on HCAHPS survey items.
The current process allows nurses to print a medication education pamphlet from
Lexicomp directly from the electronic medical record (Wolters Kluwer, 2021). The
pamphlet is a 2- to 3-page document that includes content for the patient on one
prescribed medication. The pamphlet includes brand names, what the medication is used
for, what the patient should tell the physician before taking the medication, what the
patient needs to know or do while taking the medication, side effects, how the medication
is best taken, what to do if a dose is skipped, and how to store the medication (Wolters
Kluwer, 2021). Nurses may not have sufficient time to review all this information,
highlight, or extract the most pertinent information for patients.
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This project’s intended goal is to improve patients’ medication knowledge
through evidence-based cognitive aids that will be delivered by the nurse at the bedside
using the teach-back method. The cognitive aid will be used to educate patients on how
the medications work, why the medications are being prescribed, and the medications’
side effects. Teach-back, an evidence-based method, is used to evaluate the patients’
understanding of what they have been taught. Schillinger et al. (2003) used a method they
termed interactive communication loop; this most commonly now is referred to as the
teach-back method. Schillinger et al. (2003) researched and evaluated the use of the
interactive communication loop during physician-to-patient interaction about glycemic
control to check for gaps in the patient’s understanding of the information, to reinforce
informational and educational messages, and to stimulate open conversation with the
patient. Schillinger et al. concluded that the use of recall and comprehension improved
patients’ understanding and improvement of their glycemic control. Using the teach-back
method during patient medication education could give the nurse assurance that the
patient understands how the medications work, why the medications are being prescribed,
and the medications’ side effects. The intent is to guide nurses in teaching the most
important information about the medications that the patients are receiving, with a goal of
increasing patient satisfaction scores on the three identified HCAHPS survey questions
(Institute for Healthcare Improvement, 2021).
Project Question
The project question for this quality improvement project was: What are the
evidence- and theoretically-based and validated elements of 5 cognitive aids for new,
high frequency medications commonly prescribed for patients admitted to the (infectious
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disease unit) IDU at Virtua Mount Holly? The development of cognitive aids represents
Phase 1 of a medication-education quality improvement VH strategy. Phase 2 will take
place following planned roll out of the cognitive aids and includes the evaluation of
changes in HCAHPS scores from baseline to post-implementation.
Conceptual Definitions
Cognitive aid on new medications for nurses is defined as structured,
electronically uploaded, and printable handout that nurses use to structure brief bedside
educational sessions to teach patients specific content about newly prescribed
medications prior to discharge. Cognitive aids are designed to enhance consistent
delivery of teaching points by nurses and to increase patients’ knowledge and adherence
to prescribed new medications (Stanford Medicine, 2021).
HCAHPS Standardized survey is defined as an instrument sent to patients post
hospital discharge to elicit their perceptions of the care received while hospitalized. It is a
29-item survey that assesses communication with nurses and physicians, staff
responsiveness, discharge readiness, care transitions, medication communication, and a
general question about the overall hospital experience (CMS, 2021). HCAHPS questions
related to patient education will be evaluated
Knowledge of medications is defined as comprehension of the specific facts and
concepts on conceptual content associated with drugs and acquired during instruction
with the intention of developing intellectual, conceptual abilities and skills associated
with taking prescribed drugs. Key content topics included in medication education
include the reason the patient is taking the medication, how the medication works, and
the medication’s side effects (Altin et al., 2014).
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Medication education is defined as instruction on the facts taught to hospitalized
patients about medications prescribed during hospital admission and that patients may or
may not continue upon discharge. Medication education is a well-planned, systematic,
process that prepares the patient to have full understanding of the medications they are
prescribed (Bastable, 2017).
Teach-back method is defined as an interactive strategy to determine if patients
comprehend and understand the information given to them. Teach-back method requires
the patient to repeat back the information they received, allowing the provider to assess
their understanding (Yen & Leasure, 2019)
Review of the Literature
This section includes three elements. The first addresses the PICO question,
systematized review and the search process including search terms and databases. The
second section is literature appraised and the summary of appraised and related literature.
The third section presents the framework for the quality improvement project.
PICO Question and Systematized Review
The outcome of the PICO question is future patient satisfaction scores on three
HCAHPS questions, evaluated quarterly and compared to baseline, following
implementation of evidence-based cognitive aids developed for the DNP project.
The PICO question follows:
•

P/P: Hospitalized patients’ HCAHPS surveys showed decreased scores related
to patients’ knowledge of prescribed medications.
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•

I: Nurses’ instruction on medications structured by evidence-based, cognitive
aids on high-frequency drugs prescribed for IDU patients provided using the
teach-back method.

•

C: Standard educational pamphlet obtained through VH’s electronic database
and other instruction provided by health care providers on prescribed, highfrequency medications.

•

O: Patient satisfaction scores for three questions from the HCAHPS following
future implementation of the cognitive aids structuring nurses’ instruction.

The purpose of this systematized review was to examine research on the use of
evidence-based, cognitive aids for nurses when providing instruction on newly prescribed
medications and best practices to structure the content of the cognitive aids when
providing medication education to hospitalized patients. The database searches excluded
articles older than 5 years, in languages other than English, and non-full text articles;
duplicate studies were also excluded when located in multiple search engines.
Search Strategy
The results of the search process are summarized in the search process review of
literature in Table 1.
The initial search was conducting using the Summon database from the Connolly
Library at La Salle University. Search terms were patient education AND medication
education AND HCAHPS. Inclusion criteria were English, full text, journal article, peer
reviewed, and dated 2016 to present. The initial search yielded 267 articles. The search
was performed by adding terms to limit results: patient education AND medication
education AND HCAHPS AND nurs* communication; this strategy yielded 228 articles.
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Next, the search process added terms to limit results, AND patient teaching, yielding 95
results. The records were screened by title and abstract and 5 articles were kept for
review.
The Cochrane Library was the second database searched. The terms patient
education AND medication AND cognitive aid. Four reviews were found, but when
evaluated, none had any relevance to this quality improvement project. The Cochrane
database was searched again using patient education AND medication AND HCAHPS; 7
trials were found, but when evaluated in depth none contributed to this quality
improvement project.
The third search was performed in PubMed. Inclusion criteria were English, full
text, with a date range of the past 5 years. Search terms included medication teaching
AND patient satisfaction, yielding 413 results. Adding AND nurse yielded 50 results.
Titles were reviewed and no articles were selected.
The fourth search was performed in PubMed. Inclusion criteria were English, full
text, with a date range from the past 5 years. Search terms included patient education
AND cognitive aid, yielding 29 results. After title review 2 were selected for abstract
review. Two were selected for critical appraisal.
The fifth search was performed in CINAHL complete at VH Library. Inclusion
criteria were English, full text, with a date range from the past 5 years and peer reviewed.
Search terms included patient teaching AND medication AND HCAHPS and yielded 7
results. After title review, 5 articles were selected. After abstract review, 3 articles were
kept for appraisal.

10

The sixth search was performed in CINAHL complete at Virtua Health Library.
Inclusion criteria were English, full text, with a date range from the past 5 years and peer
reviewed. Search terms included patient teaching AND medication AND patient
satisfaction, yielding 40 results. After title review 15 articles were selected for abstract
review. After abstract review, 1 article was kept for critical appraisal.
The seventh search was performed in OVID at VH Library. Inclusion criteria
were English, full text, with a date range from the past 5 years and peer reviewed. Search
terms were medication teaching AND patient satisfaction, yielding 14 results. After title
review 3 articles were selected for abstract review. Three articles were kept for critical
appraisal.
Search Summary
The initial searches included a combined 576 articles. Thirteen articles were
selected for critical appraisal. The search results are summarized in Table 1.
The results of the 13 articles critically appraised are found in Table 2. The Johns
Hopkins Nursing Evidence Based Practice Model (JHNEBP) was used to determine the
level and quality of the research (Johns Hopkins, 2021). Nine of the articles were level II
A (quasi-experimental studies/high quality), two articles were level II B (quasi
experimental/good quality), one was level IIIA (non-experimental study/high quality) and
one was level IIIB (non-experimental study/good quality).
The systemized review of the literature provided support that having a cognitive
aid or a structured evidence-based process in place to deliver patient education to
hospitalized patients may improve HCAHPS scores and patient outcomes. Literature
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supports the use of pictures, written content, and cognitive aids for nurses when provided
medication education to their patients.
Appraised Studies
Nickles et al. (2020) conducted a quality improvement project using the Model
for Improvement framework from the IHI for a pre and post implementation study. The
purpose of the quality improvement project was to increase nursing student use of teachback, ensure 80% of the patients could state name, purpose of, and side effects of current
medications, and 80% of the patients would report being satisfied with their medication
teaching. Patient satisfaction was measured by the One Minute Evaluation on completion
of the medication education (Nickles et al., 2020). Patient knowledge was measured by
the Patient Knowledge Tool immediately after completing the medication education.
Descriptive statistics were calculated on responses to questions on all tools and surveys.
The results of the quality improvement project showed that the implementation of an
evidence-based, teach-back intervention improved patients’ understanding of medication
education. Aim 1, to increase nursing student use of teach-back method by 80%, was not
met; however, the results indicated that 70.5% of the patients received medication
education using the teach-back method. The second goal of the project was to have 80%
of the patients be able to state the name, purpose, and side effects of current medications
using the Patient Knowledge Tool. Results indicated an improvement from 16.4% to
58.2% in patients’ ability to recall the purpose of the medications, and an improvement
from 1.8% to 50.9% in patients’ ability to state the side effects of the medications when
taught using the teach-back method. Although the goal on HCAHPS surveys of patients
answering always for “Staff explained the purpose of the medication” and
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“Communication of possible side effects of new medications” did not meet the
benchmark post intervention, the overall responses from patients suggested a strong
correlation between the use of teach back and an improvement in patient satisfaction.
Allenbaugh et al. (2019) developed and evaluated a curriculum for internal
medicine residents and nurses to improve communication and knowledge and attitudes
toward health literacy, their bedside communication skills with patients, and inpatient
communication-specific patient satisfaction scores. The researchers used a pre/post study
design to assess the effectiveness of the curriculum through surveys, direct observation at
bedside rounds and discharges, and communication specific HCAHPS data.
Knowledge, attitudes, and confidence of the residents and nurses from matched
pre and post surveys were analyzed using a Wilcoxon signed-rank test (Allenbaugh et al.,
(2019). Chi-square and Fisher’s exact tests were used to determine the difference
between pre-and post-communication skills checklist scores. A Chi-square test was used
to analyze HCAHPS pre-and post-data. Knowledge scores improved in both groups (p <
0.001). Confidence to translate medical information into layman’s terms improved among
nurses at a statistically significant level (p< 0.0001), but not the residents (p = 0.575)
Trotta et al. (2020) used a qualitative descriptive design to understand patients’
perceptions of their experiences communicating with nurses while hospitalized to inform
best practices for hospital nurses. Trotta et al. used purposeful sampling to interview men
and women from four age groups who were recently discharged from a large urban
academic medical center in Northeastern United States.
The researchers (Trotta et al., 2020) extracted words or ideas that represented an
idea, labeling them as codes. Once interview transcripts were coded, codes were put into
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categories that shared a meaning. Those were then grouped by themes and evaluated
using a direct content analysis approach. The analysis highlighted that patients identified
key behaviors or moments when thinking about their experience with nurse
communication. Key behaviors identified were engagement, anticipation, responsiveness,
teaching, salient episodes during which nurses’ behaviors resonated most, nighttime,
painful and/or invasive procedures, and embarrassing moments. Limitations to the study
included: underrepresentation of participants under the age of 29, the use of HCAHPS as
a frame, created a narrow frame for qualitative inquiry into nurse communication, the
mimicking of HCAHP questions likely elicited positive responses, and the organization
has one of the highest HCAHPS scores in the nation. In conclusion, the key behaviors
identified from the study can be used for hospitals to use when looking for areas of
opportunity for improvement.
Centrella-Nigro and Alexander (2017) used a pre/posttest design to test nurses’
knowledge, attitudes, and beliefs about teach-back method, based on Orem’s self-care
deficit theory. The purpose of the study was to determine if using the teach-back method
would improve HCAHPS scores on the intervention unit compared to the unit that
provided the standard of care. The quasi-experimental design study was used on two
similar medical units. The intervention group (n = 24) included permanently assigned
nurses on a designated unit that received a 1-hour teaching intervention and the control
group (n = 30) included permanently assigned nurses on a similar unit that continued to
use the standard of care for teaching patients.
Qualitative analysis of nurses’ comments demonstrated strong support for teach
back in the post-test (Centrella-Nigro & Alexander, 2017). A significant improvement in
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knowledge scores was also found (p = .002). There were no significant differences in
HCAHPS scores between the intervention and control unit. Limitations to this study
included small number of participants in the intervention group (n = 24), and factors that
affected the HCAHPS scores, such as levels of health literacy, staffing, acuity of the
patients, as well as others. In addition, the same pretest and posttest were not given to
both units involved in the study; therefore, participants’ knowledge of teach back remains
unknown. The developed instrument had a low reliability as measured by Cronbach’s
alpha, but that could be due to the low number of measured test items and sample size,
further testing of the reliability should be considered (Centrella-Nigro & Alexander,
2017).
Miller et al. (2018) conducted a randomized, quasi-experimental design study to
evaluate patients’ perceptions of medication communication during a hospital stay before
and after the pharmacy department’s initiative to provide and emphasize the importance
of patient-centered medication education. A convenience sample of 50 patients was
surveyed prior to intervention and an additional 50 patients were surveyed approximately
one month after the program’s initiation. Surveys included 5 questions to assess the
satisfaction of the medication education received while in the hospital. The questions
were:
•

How often did hospital staff speak with you about your medications?

•

How often did hospital staff speak with you about possible side effects with your
medication?

•

How often did you receive enough information to understand your medications?
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•

Who has spoken to you about your medications (nurse, physician, pharmacist, or
other)?

•

How satisfied are you with the information you received about your medications?
Favorable responses were considered if patients answered “usually” or “always”

to the questions (Miller et al., 2018). A 22% increase (p = .013) of patients responded
favorably when asked how often staff spoke about their medication. A 10% (p = .013)
increase in patients answering favorably to how often staff spoke to them about side
effects was also found. A 16% (p = .086) increase was found in patients when asked how
often they felt they received enough information. More than 50% of the patients
responded to be “extremely satisfied” with the medication education they received.
Limitations of the study included a simultaneous initiative hospital wide to improve
patient satisfaction that may have attributed to the increase in patient satisfaction, the
inability of patients to differentiate between different providers in the hospital, and
potential bias related to the use of a non-validated survey. Furthermore, convenience
sampling was used, and while no significant differences existed in baseline characteristics
of the study groups, a potential for selection bias remains (Miller et al., 2018).
Bartlett Ellis et al. (2016) conducted an analysis of cross-sectional data, merged
from HCAHPS and Magnet hospitals, to assess the relationship between patients’
perceptions of healthcare providers and medication communication. The study found
significant correlations between patients’ perceptions of communication and the
explanations they received about their medications. The study found significant
relationships between high quality communication from the healthcare providers to the
patients and patients’ perceptions of medication education (r = 0.819, p = < .001, r =
16

0.722, p < .001). The findings indicate communication as an area that needs continued
support and improvement by healthcare providers.
Gillam et al. (2016) conducted a quality improvement pre and post intervention
analysis to determine if the use of standard medication information sheet (SMIS) and
mugshots improved patient satisfaction scores and understanding of medications
Mugshots was a term created by the nurses to describe the intervention. The mugshot
consisted of a printed label that was affixed to the water pitcher that included the name of
the medication, what the medication does, and common side effects. The goal of the
intervention was to improve patient education about new medications and side effects,
and to significantly improve the HCAHPS medication communication scores. The
intervention was combined with existing methods. The use of the SMIS and mugshots
(post intervention) were compared to the standard of care and use of SMIS only (pre
intervention).
A Mann Whitney U test was used to identify internal survey response
differences between pre and post intervention (Gillam et al., 2016). A 30-day phase 1
period showed an increase in the number of patients that could recall medication
specifics. Seventy-nine percent surveyed were able to tell the side effects of the
medication compared to the pre percentage of 41%. How patients were instructed on
medication side effects increased to 73% compared to the pre percentage of 55%. A PlanDo-Study-Act was performed after Phase 1. HCAHPS scores “Before giving you a new
medicine, how often did hospital staff tell you what the medicine was for?” and “Before
giving you any new medicine, how often did hospital staff describe possible side effects
in a way you could understand?” increased from 55% (previous quarter) to 81% after
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phase 2. Gillam et al. concluded that intuitive medication reminders and medication
information sheets used together are more effective than if used independently.
Prochnow et al. (2019) conducted a quality improvement project guided by the
Ottawa Model of Research Use (OMRU) using a prospective approach with a 1-group
pre-and post-education design with registered nurses (RNs), patients, and caregivers. The
purpose of the project was to improve patient outcomes by using a tailored, evidencebased intervention (teach-back), assisting RNs to effectively educate and monitor patient
knowledge of new medications on three units. However, a comparison of patient
outcomes was made only on the demonstration unit: pretest teach-back and posttest teach
back, after education and implementation of the teach-back method. During the period of
data collection, a total of 123 medications were given to patients. One hundred nineteen
(97%) of patients or caregivers could remember the purpose of the medication and were
able to remember side effects on 81 of the medications (66%). Although patients on all 3
units received the education on teach back, only the demonstration unit participated in the
pre and post education test.
Comparison of pre and post implementation of HCAHPS scores on the
demonstration unit using McNemar’s test analyzed RN pre and post education use and
understanding of teach back (Prochnow et al., 2019). The RNs reported increased
conviction, confidence, and frequency of teach-back on a post intervention survey on the
relevance and satisfaction of teach back on their practice. HCAHPS survey results on
average increased from 6% to 10% on the following questions: “During the hospital stay,
how often did RNs explain things in a way you could understand” (question 3); “Before
giving you any new medicine, how often did hospital staff tell you what the medicine was
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for” (question 16); “Before giving you a new medicine, how often did hospital staff
describe possible side effects in a way you could understand (question 17)” (Prochnow et
al., 2019).
Lam et al. (2019) conducted a quasi-experimental, 2-week prospective study
using a convenience sample of patients that were admitted to the hospital. The purpose of
the study was to determine the effect of the use of PLAN (Preparing for next visit,
Learning and sharing concerns, Asking questions, and Noting what to do next) on three
questions: How well do you understand your health condition and How well do you
understand what your medications are for? and How well do you understand how to take
your medication? Patients were grouped by initiated or already taking a high-risk
medication. During a 2-week period, pharmacists delivered the intervention (PLAN) to
eligible patients. A total of 38 patients participated; however, outcome data for only 26
patients were analyzed.
Pre and post questionnaires were administered to patients via mobile app or
paper (Lam et al., 2019). The primary outcome, health knowledge scores, measured
before and after PLAN implementation, were compared using a 2-tailed t-test. Secondary
outcomes that included measuring of the clinical pharmacy interventions made by the
pharmacists, patient satisfaction, and pharmacist accessibility, were characterized by
descriptive statistics. Results showed all three outcome variables improved post
intervention, but only two reached statistical significance (p <0.05): How well do you
understand your health condition and How well do you understand what your
medications are for? How well do you understand how to take your medication? did not
reach statistical significance.
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Jones and Coke (2016) developed, implemented, and evaluated an evidencebased, standardized approach to patient education on new medications and evaluated the
outcomes of the program. They compared pre and post intervention HCAHPS scores on
the new medication domain. The post intervention evaluation study was conducted on 2
medical-surgical units. A 21-question posttest and telephone surveys were administered
to evaluate patient knowledge within 72 hours of discharge. Results showed an increase
in the HCAHPS new medication domain by 11.4% when compared to the preintervention
scores. Eighty-three percent of patients called post discharge provided teach back details
on at least 1 medication and 1 side effect post implementation.
Paitag et al. (2020) performed a quasi-experimental intervention study to
determine if the use of errorless teaching/learning (ETL) methods and pictorial cards on
medications improved RN teaching and patient medication adherence in persons with
cognitive challenges. Paitag et al. used a convenience sample of RNs caring for persons
with cognitive challenges and persons with cognitive challenges after collecting baseline
data over 4 months. The intervention included use of the ETL by nurses and a pictorial
card about medications. The pictorial cards were originally developed by Paitag and
Highfield (2017) and modified for this study. The pictorial cards included the medication
name, when to take the medication (with picture depicting time of day included), the
dose, purpose of the medication, side effects, and need for or not to take medication with
food. Patients’ discharge medication adherence was measured by the Medication
Adherence Score Sheet (MAS) adapted from Hawkins and Firek (Paitag et al., 2020)
Variables on RNs were measured using the Teaching Discharge Meds Questionnaire
(TDM) and Observational Tool (OT). At baseline, no medication education was observed
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in 35% of RN teaching encounters, compared to 100% that used at least one strategy to
teach about medications post intervention. The ETL and pictorial card of medication
improved RN teaching and possible patient adherence.
Yeoh et al. (2020) conducted a quality improvement study to assess compliance
with the Antimicrobial Stewardship Clinical Care Standards on information given to
patients about their antimicrobial treatment while in the hospital. A convenience sample
of hospitalized adult patients who were receiving or received one or more antimicrobials
for greater than 72 hours was used to meet the needed sample size. The sample size of 50
was determined to be adequate when analyzing baseline communication practices and the
development of quality improvement resources and actions. A paper-based survey was
conducted between November 2018 and February 2019. The survey was designed to
address identified antimicrobial stewardship clinical care standard 3 and 5.
A patient with a suspected infection, and/or their carer, receives information on
their health condition and treatment options in a format and language that they
can understand (standard 3) and When a patient is prescribed antibiotics,
information about when, how and for how to take them, as well as potential side
effects and a review plan, is discussed with the patient and/or their carer (standard
5). (Yeoh et al., 2020, p. 303)
Only 18% of the patients knew side effects of the medications they were
receiving, 25% were informed about how to take their medications, and only 11%
received written information about the antimicrobial medication they were receiving
(Yeoh et al., 2020). The results identified gaps in communication with patients regarding
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in-hospital antimicrobial therapy and highlighted the need for a creation of improvement
activities to address the gaps.
Price (2019) conducted a pre/post quality improvement project to increase
patient knowledge of new medication adverse reactions described by staff. The outcomes
of concern were scores on the following HCAHPS question, “Before giving you any
medication, how often did hospital staff describe possible adverse reactions in a way you
could understand?” The project was conducted on a 30-bed progressive care unit that had
consistently low HCAHPS survey responses related to medication education. All patients
admitted to the unit during the intervention period were included in the study. The
intervention included an adhesive shipping label with preprinted common adverse
reactions and numerical risk indicators for the unit’s most frequently administered
medications. When each patient received one of the medications with its preprinted label,
the nurse affixed the label to the patient’s water pitcher. A log recorded the patients to
whom the labels were provided. As a result of the intervention, the mean score related to
medication adverse reaction education increased from 48.5% to 68.9% post intervention.
Price’s study suggests that new medication interventions could increase patients’
understanding of medications and improve HCAHPS scores on specific medicationrelated items.
Related Literature
Knapp et al. (2004) conducted a randomized controlled study to compare two
methods of presenting information to patients about side effects of medications. The
study participants were given information on the likelihood of side effects of medications
occurring using two condition formats: verbal (rare, common) and numerical (0.04%, 1 in
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12). The study revealed that when participants received the information about the
likelihood of the side effects in verbal terms (rare, common) versus a numerical term
(0.04%, 1 in 12) they thought the side effects would occur far more frequently. When the
term “common” was used, those surveyed believed the side effect would occur on
average 34%, when the incidence of the side effect occurring was between 1% to 10%.
When the term “rare” is used, the intended rate of side effect incidence is 0.01% to 0.1%,
however those surveyed, believed the probability of the side effect occurring was closer
to 20%.
Ahrens and Wirges (2013) developed a quality improvement program, Always
Ask, for nurses at a for-profit, Midwestern tertiary care facility. A patient information
handout was developed and inserted in admission folders, with a message that reminded
patients to always ask questions about what the medication is, why they are taking it, and
what the side effects may be. The nurses were also provided information about the
program and support was given to them throughout the quality improvement project.
Pre-intervention HCAHPS scores revealed a little less than 30% of respondents answered
always when asked how often hospital staff described possible side effects in way they
could understand. Post intervention HCAHPS scores increased to 77.3% of respondents
that answered always to the same HCAHPS question as pre-intervention.
Talbot (2018), a new graduate nurse in a nurse residency program at Beebe
Health system in Delaware, incorporated medication education sheets into practice when
giving a patient new medication. The medication education sheets had the most common
side effects in one column next to the most prescribed medications in the adjacent
column. The nurses were instructed to highlight the medication the patient was receiving
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and the drug’s side effects when verbally introducing the patient to the medication. The
sheet was given to the patient for reference. The result of the quality improvement project
showed an increase in the HCAHPS scores for the unit on “Before giving you any new
medication, how often did hospital staff tell you what the medicine was for?” and
“Before giving you any new medication, how often did hospital staff describe possible
side effects in a way you could understand?”. HCAHPS scores related to teaching about
new medications increased from 62.5% to 100% post intervention, and scores for staff
describing side effects increased from 12.5% to 71.4% post implementation (Talbot,
2018).
Overall Summary
Much of the research cited supports the need for a formal, structured medication
education tool, due to the continued lack of medication education the patients perceive to
have received while hospitalized. An abundance of research was available on medication
education and patient satisfaction, but few studies were located that discussed the link
between a cognitive aid and medication teaching improving patients’ understanding of
the medications they receive when in the hospital. The literature search also supported the
use of teach-back to appropriately assess if the patient understands the education and
information provided. The review and appraisal of the literature supports the need for a
continued improvement in the delivery of medication education to patients.
Theoretical Framework
The theory of adult learning introduced by Malcom Knowles in the late 1970s
serves as the theoretical framework for this quality improvement project. Knowles’s
(1970) theory of adult learning consists of 6 assumptions. The assumptions are: (1)
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Learners need to know why, what, and how; (2) Learners need to feel self-directed and
responsible for learning; (3) Prior experiences should be built upon to aid in the learning;
(4) Learners need to be motivated and understand how what they are learning will
directly affect them and their life; (5) Content should not be generalized, instead should
be specific to solve the problem; and (6) Learners must be motivated to learn (Knowles et
al., 2005).
Knowles (1984) also introduced the four principles of andragogy about the time
he introduced the fifth and sixth assumptions. The principles are: (1) Adults want to be
part of the planning and evaluation of the instruction; (2) Experience, both positive and
negative, function as the basis for all learning activities; (3) Adults naturally drift towards
learning things that are relevant in their personal life; and (4) Adult learning evolves
around problems (Norrie & Dalby, 2007). Most adult learners are only interested in
learning new knowledge if the new knowledge directly benefits them in some way.
This framework is associated with patient medication teaching and how patients
can be best taught and understand the education provided while in the hospital. Patients
want to be part of the learning process, therefore involving them and providing them
information allows them to access it when ready and when convenient. When educating
patients on medications, it is important to link the why it is important to know this
information in terms that the patient will understand, varying with every patient, and
dependent on their literacy, education level, and life experiences. As Knowles (1984)
described, adult learners are mainly interested in learning only if they know the result
will benefit them.
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Method
Design
The DNP project is part of a quality improvement initiative at a hospital in South
Jersey to create and validate cognitive aids for 5 high frequency medications prescribed
for patients prior to discharge from the hospital. To determine the 5 high frequency
prescribed medications, a report from electronic health record (EHR) was run with the
dates of January 2019 to January 2020. The dates for the report preceded the
hospitalization of COVID patients, to provide an accurate account of the most frequently
used medications. The unit for the QI project is the primary COVID unit for the hospital.
Medication instruction will also incorporate nurses’ use of teach-back method with their
patients. The project uses a program planning (Appendix A) approach that addresses the
(a) creation of cognitive aids and (b) reinforcement education on teach back.
The specific project addresses the gap in practice related to nurse communication
and education about new medications as evidenced by low HCAHPS scores for an IDU.
This doctoral project developed evidence-based cognitive aids for RNs to teach patients
about new medications. The cognitive aids may assist nurses to educate patients on first
dose medications and to improve patients’ perceptions of their care while in the hospital.
Having an evidence-based education process in place for the nurses to utilize may
improve patient outcomes, as evidenced by HCAHPS scores on specific items following
rollout of the cognitive aids. The design for the development of the medication cognitive
aids is descriptive qualitative. The data sources are empirical, theoretical, current
textbook, and hospital literature on the 5 identified medications. Content experts
evaluated draft cognitive aids and provided ranks and comments on the 5 medications.
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Sample and Setting
The setting for the DNP project was a 36-bed medical surgical, IDU at a large
hospital system in South Jersey. The sample is the empirical, theoretical, current
textbook, and hospital literature that describes or addresses the five medications included
in the cognitive aids and additionally for methods on effective delivery of patient
education and medication education. Different literature sources were used for the
teaching process and the medication-specific content of the cognitive aids.
Ethical Considerations
The healthcare organization’s Institutional Review Board (IRB) is the primary
approval committee for this project. After completing the QI or research-differentiating
tool, which validated the proposal is a QI project, it was sent to the Evidence Based
Practice and Nursing Research Council for review and was approved. See Appendix B.
Instrumentation
Instrument Development
Teaching Process. The inductive qualitative analysis method of Graneheim and
Lundman (2004) was used to develop the cognitive aids in relation to patient education
and teaching processes. The empirical and theoretical literature was used as data sources.
A 5-column table was created in Microsoft Word® (Redmond, WA) with the following
headings: Meaning Unit, Condensed Meaning Unit, Interpretation of Meaning Unit, Subtheme, and Theme (Appendix C) to document the structure and necessary components of
patient education.
Cognitive Aids. Next, Graneheim and Lundman’s (2004) deductive qualitative analysis
was used to identify codes in the literature specific to the five medications. The empirical,
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theoretical, textbook, and hospital literature was used as data sources. The deductive
coding scheme included different categories: the names of the medication generic and
trade names, how the medications work (therapeutic actions), why the medications are
being prescribed (reasons for prescription), and the medications’ side effects. Deductive
content analysis was applied to create a deeper understanding of medication information
that is necessary for patient teaching (Appendix D). Additionally, a summary of the
teach-back method was added in bullet form to each cognitive aid based on analysis of
the literature (Prochnow et al., 2019). The draft of the cognitive aids sent to the content
experts is located in Appendix E.
Cognitive Aid Expert Content Validity
Content validity was established with content experts (Appendix F) on medication
content and teaching processes by invitation to participate via email. Experts were an
interprofessional group of health care providers. The experts consisted of three DNPprepared nurses, a PhD-prepared nurse (traditional experts), a clinical pharmacist, and
nurse directors (experiential experts). The experts were asked to use an item content
validity index (I-CVI) (Polit & Beck, 2006) to review the draft cognitive aid items and a
survey content validity index average (S-CVI/Ave.) to evaluate the overall relevance of
the teaching aids. The comments of the experts were reviewed, and a document was
created including comments from the reviewers (Appendix H).
A 4-point scale was used on all items of the 5 cognitive aids (Polit & Beck, 2006).
The item scaling includes the following: 1 = not relevant; 2 = somewhat relevant; 3 =
quite relevant; and 4 = highly relevant. The project director computed the I-CVIs and SCVI/Ave., following the approach of Polit and Beck (2006) on the relevant components
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of the 5 cognitive aids.
The cognitive aids were revised and updated based on content expert scores and
comments. Once the final version of each component of the medication cognitive aid was
completed, the cognitive aids will be submitted to VH’s Patient and Family Education
Council for approval and subsequent use on the IDU.
Data Collection
The first data sources were the research articles obtained during the systematized
literature review of the following databases: Cochrane Library, OVID, PubMed,
Summon, and CINAHL. Empirical and theoretical literature informed the teaching
processes. Additional peer-reviewed data sources for the medication content of the
cognitive aids included pharmacology textbooks, hospital documents such as patient
handouts, online resources available for nurses through the hospital intranet, such as
Lexicomp, a drug reference for hospital wide or community physicians, and Krames
(2022), an evidence-based provider of patient education. Krames is an online evidencebased provider of patient education; nurses within the healthcare system have access to
content available to assist with patient teaching. Themes were generated from the
literature that assisted in the structuring of the cognitive aids. Teach-back bullet points
were added to the bottom of the draft cognitive aids for the nurse to have easy to access
to important teach-back concepts.
The Expert Content Validity Form (Appendix F) was emailed to an
interprofessional group of experts on medication knowledge. The email directed the
experts to review each cognitive aid individually and rank each item on a 4-point scale.
The PD asked that the completed content validity forms be returned to the project director
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within three weeks on receiving the email. Along with ranking each item of the cognitive
aid, the interprofessional group of experts were also asked to type in recommendations
and comments on each item.
Data Analysis
Inductive qualitative content analysis was based on Graneheim and Lundman’s
(2004) methods. The inductive qualitative analysis approach allowed the project director
to compare the different concepts or themes against each other after data collection of the
various literature sources for the teaching processes and the medication content of the
teaching aids.
The literature was read and reread to obtain an understanding of the common
themes. The common themes for effective patient education and teaching processes
included: Teach-back, accommodation of low health literacy, information needs to be
reinforced and consistent, and the technique and method of instruction is very important
for patients to understand medication education were identified and used to create the
cognitive aids.
The literature sources were also analyzed using deductive content analysis
(Graneheim & Lundman, 2004) to interpret the meaning of the medication-associated
content of empirical, theoretical, textbook, and hospital resources, and other textual
sources to create a cognitive aid useful for both patients and nurses. When reading and
rereading the resources, the main themes or deductive codes for each medication were
identified. The most common side effects, usage of medication, and how the medication
works themes were identified and used for the creation of the cognitive aid.
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The cognitive aids were created and reviewed by the content experts. The experts’
rankings and comments were entered into a Microsoft Excel (Redmond, WA) spreadsheet
and calculated I-CVIs for each item and S-CVI/Ave. The comments and
recommendations made by the content experts were organized into an Excel spreadsheet
(Appendix H) and edits were made to the cognitive aids based on the I-CVIs and SCVI/Ave as were comments of the content experts. To further validate the readability of
the draft cognitive aids, each aid was analyzed for the Flesch-Kincaid Grade level
(Flesch, 1948) readability score (Microsoft Word, Redmond, WA). Scores are an
indication of grade level and based on the number of syllables in word on the cognitive
aids. The goal for the Flesch-Kincaid Grade level for all the cognitive aids is below or at
a sixth grade reading level to be readable for the majority of patients.
Inductive and deductive qualitative analysis and the cognitive aid expert validity
was used to create data source triangulation from the empirical, theoretical, textbook,
hospital resources, and other textual sources. Triangulation is used in qualitative research
to gain a more thorough understanding of what is being analyzed (Carter et.al., 2014).
Triangulation can add clarity to qualitative analysis and is considered a strategy that joins
data from different sources (Carter et.al., 2014), creating a better perspective and
validation of the data.
Results
Content Analysis of Literature and Draft Cognitive Aids
The literature was analyzed using both inductive and deductive qualitative
analysis to draft the first version of the cognitive aid for each medication. Analysis of the
literature determined themes for effective patient teaching processes regarding
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medication education (Appendix C). The literature was analyzed for each medication;
codes/themes were recorded. See Appendix D. The findings informed the 5 draft
cognitive aids.
Expert Content Validity
Six experts reviewed the 5 draft cognitive aids. Item CVIs ranged from .167 to 1.0
over all elements of the 5 cognitive aids. The S-CVI/Ave. ranged from .833 to .897 over
the 5 cognitive aids. Recommendations from the experts suggested the need for the teachback points to be at the top of each cognitive aid. Also, if an item’s I-CVI was low, the
project director made changes based on recommendations. Although the I-CVI for dosage
of medication had the lowest I-CVI, the dosage was retained on all cognitive aids.
However, the dosage position was moved toward the top of the page. The Project Team
Chair also recommended changes. The project director revised the draft cognitive aids.
Revised Cognitive Aids
After the cognitive aids were revised, the project director recalculated the FleschKincaid Grade level (Flesch, 1948) for each cognitive aid:
Ceftriaxone (Rocephin) = 5.4,
Vancomycin (Vancocin) = 6.1,
Piperacillin/tazobactam (Zosyn) = 5.6,
Hydromorphone hydrocholoride (Dilaudid) = 6.1, and
Calciparine (Heparin ™) = 5.1.
All 5 cognitive aids had a Flesch-Kincaid Grade level (Flesch, 1948) between 5.1 and
6.1, meeting the recommended sixth grade reading level for patient education. See
Appendix I for final changes.
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Discussion
The purpose of this quality improvement project was to create and validate
cognitive aids for high frequency, prescribed medications to be used with the process of
the teach-back method (Yen & Leasure, 2019). The aim of the project was to assist
bedside nurses that teach patients to increase and reinforce patients’ knowledge of
prescribed medications prior to discharge, and after implementation to increase patient
satisfaction as indicated by HCAHPS scores. The project’s cognitive aids will be shared
with the Patient and Family Education Council and the IDU’s RNs.
The project director analyzed relevant literature using the inductive and deductive
qualitative analysis method of Graneheim and Lundman (2004) to develop the necessary
components and content of the evidence-based, draft, cognitive aids for the IDU.
Consistent with the quality improvement focus of the project, the project director added
the steps of the teach-back method on each of the cognitive aids (Schillinger et al., 2003).
The project director calculated the Flesch-Kincaid Grade level on the draft versions of 5
cognitive aids: Ceftriaxone (Rocephin™) Cephalosporin; Vancomycin (Vancocin™)
Glycopeptide antibiotic; Piperacillin/Tazobactam (Zosyn™) Penicillin extended
spectrum; Hydromorphone (Dilaudid™) Opioid analgesic; and Calciparine (Heparin™)
Indirect thrombin inhibitor.
The project director sent the 5 draft cognitive aids to six experts, both traditional
and experienced. The experts represented an interprofessional group of RNs and a
clinical pharmacist. Experts participated in the expert content analysis process by ranking
the components and content of the 5 aids. She analyzed the ranks (I-CVIs on each
medication and overall S-CVI/Ave. on each medication) and comments on each item. She
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revised the cognitive aids and shared them with the Project Team Chair who also
suggested revisions. The project director recalculated the Flesch-Kincaid Grade levels for
each medication. They were at fifth or sixth grade levels.
Limitations
This project has limitations. First, a novice investigator conducted the content
analysis of the literature, including empirical and peer-reviewed literature. Next, the
project is a new initiative; it is not certain that it will affect patient satisfaction scores on
HCAHPS items (staff described medication side effects, told what the medicine was for,
and nurses explained things understandably) after dissemination. It is also not known
whether a shorter document is preferable to the hospital-based literature on specific
medications for increasing patients’ knowledge of their prescribed medications.
Implications
Much emphasis has been placed on improving nurses’ communication about
medications scores on HCAHPS items in hospital settings, particularly regarding nurses’
explaining crucial information on medications in a way patients understand. They need to
know their medications’ names, to describe medication side effects, and to report what
the medications are for. If patients have a better understanding of medications they are
receiving, both in the hospital and for continued use at home, their adherence to the
medication regimen could increase and HCAHPS scores might increase. The creation of
cognitive aids for additional medications could potentially become the standard within
VH and other health care systems.
Future Projects and Plans
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VH leaders will most likely review the cognitive aids and identify which RNs will
lead a project team to develop cognitive aids for other medications prescribed for patients
in the VH hospitals. The creation of additional cognitive aids calls for a collaborative
effort with input from different members of the health care team. Additionally, it is
important to ensure that cognitive aids have essential, updated information for patients
while not inundating them with information. Another consideration for creating cognitive
aids for a healthcare system is developing a routine process for reviewing cognitive aids
so that they are reviewed by a team on a regularly scheduled basis to ensure patients are
receiving the most current information.
The creation of a standardized cognitive aid has been successfully completed as
evidenced by the completion of Phase 1 of the quality improvement initiative and this
DNP project. Phase 2 will take place following a planned roll out of the cognitive aids
and includes the evaluation of changes in HCAHPS scores from baseline to postimplementation. In addition, the project director is interested in creating additional
cognitive aids for other frequently prescribed medications.
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Table 1
Search Process Review of Literature
Database

La Salle
Summon
Cochrane
Library
PubMed
CINAHL
Complete
OVID

Total
Articles

Articles
Remaining
After Title
Review

Articles
Retrieved
and
Examined

Articles
that fit
Inclusion
Criteria

12

Articles
Remaining
After
Abstract
Review
5

95

5

5

7

5

0

0

0

413

50

4

2

2

47

15

15

5

4

14

20

3

3

3
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Table 2
Appraised Literature
Database
# Article
Summon #1
Nickles et al.
2020)

Purpose of
Study

Theory/
Conceptual
Framework

Design

Measurement
Major Variables

Data

Findings

To increase
nursing
student use of
teach-back,
ensure 80% of
patients could
state name,
purpose of,
and side
effects of
current
medications,
and 80% of
patients were
satisfied with
their
medication
teaching

The Model
for
Improveme
nt
framework
from the
IHI.

Pre and post
implementatio
n study.
37 bed unit
within 700-bed
nonprofit
health system
over 3-month
period.
Quality
Improvement
using the
Model for
Improvement
and PDSA
method to
improve
medication
education.

Patient satisfaction
was measured by
One Minute
Evaluation upon
completion of
medication
education.
Patient knowledge
measured by
Patient Knowledge
Tool immediately
after completing
medication
education.

Descriptive
statisticsnumerical
value
assigned to
responses for
questions on
all tools and
surveys.

Implementation of
an evidence based
teach back
intervention
improved patient’s
understanding of
medication
education.
STATS?
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Level of
research
strength
Level II
A

Summon #2
Allenbaugh et
al. (2019)

To improve
communicatio
n and
knowledge and
attitudes
toward health
literacy, their
bedside
communicatio
n skills with
patients, and
inpatient
communicatio
n-specific
patient
satisfaction
scores.

Pre/post study
design to
assess
effectiveness
of curriculum
through
surveys, direct
observation at
bedside rounds
and discharges,
and
communication
specific
HCAHPS data.
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Resident and
Nurse Knowledge,
Attitudes, and
Confidence
Resident and
communication
skills
Patient satisfaction

Knowledge,
attitudes, and
confidence of
the residents
and nurses
from
matched pre
and post
surveys were
analyzed
using a
Wilcoxon
signed-rank
test.
Chi-squared
and Fisher’s
exact tests
used to
determine the
difference
between preand postcommunicati
on skills
checklist
scores.

Knowledge scores
improved in both
groups (p < 0.001).
Confidence to
translate medical
information into
layman’s terms
improved
statistically
significantly
among nurses (p<
0.0001), but not
residents (p =
0.575)

Level II
A

Summon #3
Trotta et al.
(2020)

Understand
patients’
perceptions of
their
experiences
communicatin
g with nurses
while
hospitalized to
inform best
practices for
hospital
nurses.

HCAHPS
Nurse
Communica
tion domain

Qualitative
descriptive
study
Purposeful
sampling
strategy to
interview men
and women
from four age
groups who
were recently
discharged
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Extracted meaning
words or ideas that
represented an
idea, labeling as
codes. Once
transcripts were all
coded from
interviews, codes
were put into
categories that
shared a meaning.
Those were then
grouped by themes
and evaluated.

Chi-squared
used to
analyze
HCAHPS
pre-and postdata.
Stata 15
(StatCorp,
LLC,
College
Station, TX)
A directed
content
analysis
approach

Patients identify
key behaviors or
moments when
thinking about the
experience with
nurse
communication.

Level III
B

Summon #4
Centrella-Nigro
& Alexander
(2017)

To determine
Orem’s selfif using teach
care deficit
back method
theory
would improve
HCAHPS
scores on
intervention
unit compared
to unit that
provided
standard of
care.

Pre/posttest
design tested
nurses’
knowledge,
attitudes, and
beliefs about
teach-back

Summon#5
Miller et al.
(2018)

Evaluate
patient’s
perception of
medication
communicatio
n during

Pre/post
surveys

IV: Intervention
group:
permanently
assigned nurses on
a designated unit
(received a 1-hour
teaching
intervention)
IV: Control group:
permanently
assigned nurses on
a similar floor
(continued to
supply the
standard of care
for teaching
patients)
IV VARIES 2
WAYS
DV: knowledge
scores
DV: intervention
(pharmacy
departments
medication
education) vs
control group
45

Quasiexperimental
Paired t test

Significant
improvement in
knowledge scores.
Qualitative
analysis of nurses’
comments
demonstrated
strong support for
teach back in posttest.
HCAHPS scores
were not
significantly
improved when
comparing
intervention unit
compared to
control unit.

Level II
A

Randomized
quasi
experimental
Wilcoxon
rank-sum
test-

A significant
increase in patient
satisfaction with
medication
communications
was demonstrated

Level II
B

hospital stay in
before and
after pharmacy
department’s
initiative to
provide and
emphasize
importance of
patientcentered
medication
education.

CINAHL # 1
Bartlett Ellis et
al. (2016)

Relationships
of patient
perceptions of
healthcare
provider and
medication
communicatio
n

Analysis of
cross-sectional
data merged
from HCAHPS
and Magnet
hospitals

46

continuous
variables and
categorical
variables that
were ordinal.
Pearson chisquare tests
or Fisher’s
exact tests
when
expected cell
count was
less than
fivecategorical
variables
Descriptive
statistics
Statistical
comparison
between
hospital
categorical
characteristic
-Pearson’s
chi-squared
test

following
initiative.
P < 0.001

Level III
A

Independent
samples-ttest
Estimate the
association
of the
percent of
“always”
response –
Pearson’s
correlation
coefficient
CINAHL #2
Gillam et al.
(2016)

To determine
if the use of
SMIS and
mugshots
educate patient
about new
medications
and side
effects
significantly
impact
HCAHPS
reported
medication

Quality
improvement
pre and post
intervention
analysis
PDSA after
phase 1

DV: use of the
SMIS and mug
shots vs IV:
control (use of
SMIS only)
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GNU PSPP
Statistics
version 0.8.5
Mann
Whitney U
test was used
to identify
internal
survey
response
differences
between pre
and post
intervention

30-day phase 1
period showed an
increase in patients
that could recall
medication
specifics increased
by 93%, how they
were instructed on
medication side
effects increased
by 33%
HCAHPS scores
increased from

Level II
A

communicatio
n scores when
combined with
existing
methods

CINAHL #3
Prochnow et al.
(2019)

Improve
patient
outcomes by
using a
tailored,
evidencebased
intervention
(teach-back)
allowing RNs
to effectively
educate and
monitor
patient
knowledge of

Ottawa
Model of
Research
Use
(OMRU)

Prospective
approach with
a 1-group preand posteducation
design with
RNs, patients,
and caregivers.
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Comparative pre
and posttest after
education and
implementation of
the Teach back
method on the
demonstration
unit.
Although all 3
units received the
education on
Teach Back, only
the demonstration
unit participated in
the pre and post
education test

Comparison
of pre and
post
implementati
on of
HCAHPS
scores on the
demonstratio
n unit
McNemar’s
test was used
to analyze
the RN pre
and post
education use
and

55% (previous
quarter) to 81%
Intuitive
medication
reminders and
medication
information sheets
used together are
more effective than
if used
independently.
RNs reported
Level II
increases in
A
conviction,
confidence, and
frequency of teachback, HCAHPS
increased from 6%
to 10%

new
medications
CINAHL #4
Lam et al.
(2019)

Determine the
effect of the
use of PLAN
(Preparing for
next visit,
Learning and
sharing
concerns,
Asking
questions, and
Noting what to
do next)
Patient selfreported health
understanding
of their health
condition and
medications

Quasiexperimental
2-week
prospective
study using a
convenience
sample of
patients that
were admitted
to the hospital
and either were
initiated or
already taking
a high-risk
medication.
During the 2week period,
pharmacists
would deliver
an intervention
(PLAN) to
eligible
patients
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Pre and
postquestionnaire
administered to
patients either via
mobile app or
paper based

understandin
g of teach
back
Descriptive
statistics
Primary
outcome of
health
knowledge
scores before
and after
were
compared
using two tailed t-test
Secondary
outcomes
characterized
using
descriptive
statistics

All three outcomes
improved post
intervention, but
only 2 reached
statistical
significance
P<0.05, how well
do you understand
your health
condition and how
well do you
understand what
your medications
are for?

Level II
B

OVID #1
Jones & Coke
(2016)

Develop,
implement,
and evaluate
an evidencebased,
standardized
approach to
new
medication
patient
education and
evaluate the
program.

OVID #2

Does use of
errorless

Total of 38
patients
participated,
however
outcome data
for only 26
was able to be
used
Postinterventio
n evaluation
study on 2
medicalsurgical units.
Comparison of
pre and post
intervention
HCAHPS
scores.

21-question
posttest
Comparison of pre
and
postintervention
HCAHPS scores
Telephone surveys
to evaluate patient
knowledge within
72 hours of
discharge.

Patients’ discharge
medication

Intervention
study
50

HCAHPS new
Level II
medication domain A
increased by
11.4% when
compared to the
preintervention
scores.
83% of the patients
called post
discharge were
able to teach back
at least 1
medication and 1
side effect
postimplementatio
n.
Unpaired t
tests,

Errorless teaching
and pictorial card

Level II
A

Patiag et al.
(2020)

teaching/learni
ng methods
improve RN
teaching and
patient
medication
adherence in
persons with
cognitive
challenges

PubMed #1
(Yeoh et al.,
2020)

Assess the
compliance
with the
Antimicrobial
Stewardship
Clinical Care
Standards of
the
information
given to
patients about
their

Quasiexperimental
Convenience
sampling of
RNs and
persons with
cognitive
challenges

adherence
measured by the
Medication
Adherence Score
Sheet (MAS)
adapted from
Hawkins and Firek
RN variables were
measured using
Teaching
Discharge Meds
Questionnaire
(TDM) and
Observational
Tool (OT)
Quality
Categorical
improvement
questions on
Convenience
survey measured
sample
quantitatively and
Sample size of additional
50 to analyze
feedback from
baseline
patients was
communication collated and
practices and
measured
development
qualitatively
of quality
improvement
51

pre/post
patient
groups
Paired t-test
used for
TDM results

of medication
improved RN
teaching and
possible patient
adherence

Narrative
summary

Identified gaps in
communication
with patients
regarding in
hospital
antimicrobial
therapy, addressed
the need for a
creation of
improvement
activities to
address the gaps

Level II
A

PubMed #2
Price (2019)

antimicrobial
treatment
while in the
hospital
Improve
patient
knowledge of
new
medication
adverse
reactions

resources and
actions

Ottawa
Model of
Research
Use

Pre/post
quality
improvement

IV: Medication
education
DV: patient
understanding of
medication
HCAHPS scores

52

Narrative
summary

The mean score
Level II
related to
A
medication adverse
reaction education
increased from
48.5% to 68.9%
post intervention

Appendix A
Program Planning Matrix
Program Goal 1: To improve patient’s medication knowledge through the use of an evidence-based cognitive aid.
Program Goal 2: To promote the use of the cognitive aid by nurses when educating patients on medication.
Program Goal 3: To educate the nurse to deliver education using the teach-back method
Objectives

Methods and
Techniques

Timeline

Evaluation
Methods

Responsible
Personnel

Outcomes

1. Identify
Administrative
administrative/stakeholder organization
support.
endorsement.

April 2021

Assistant Vice
K. Pilong
President (AVP)
of
Medical/Surgical
and ICU Patient
Care Service
Line

Endorsement by
Virtua nurse leaders
obtained.

2. Determine the 5 high
frequency medications on
the IDU at Mount Holly.

June 2021

Electronic
Health Record
(EHR) report
obtained from
pharmacy.

Ran report and have
the 5 most
frequently
prescribed
medications.

Short Term Objectives:
By the end of October 2021

Obtain report from
electronic health record
(I) that have the most
frequently prescribed
medications from
January 2019 to January
2020 to account for
medication that has
been administered
during COVID.
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K. Pilong

3. To restart a patient and
family education
committee to review
education given to
patients and family
members while
hospitalized.

Identify potential
members for committee
and recruit from all
divisions.

November
2021

DNP Project
Team review

K. Pilong

Review of the
educational
components’ teaching
modules.

January
2022

DNP Project
Team review

K. Pilong

DNP Project
Team review

K. Pilong

AVP of
Medical/Surgical
and ICU Patient
Care Service
Line

Intermediate-term Objectives:
By the end of April 2022
1.Develop 5 cognitive aids
for high frequency
medication on 3NE.

DNP Project
Team

Engagement of nurses
on the unit
2.Develop education for
nurses on teach back method.

Tutorial of Virtua Nurse
share point site that lists
mentors with areas of
specialty.

January
2022

3. Collect baseline data on
HCAHPS scores for the 3
months leading up to
implementation of cognitive
aids.

Review data from
surveys completed

January
2022
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DNP Project
Team
K. Pilong

Long-term Objectives:
By the end of August 2022
1. To maintain use of
cognitive aid for medication
education of patients by
expanding the medications
aids available.
2. To develop a smart phrase
for nurses to use that will
allow the integration of the
education to be placed in the
patient’s EHR with just a few
words.

Expand the cognitive
aids.

August
2022

DNP Project
Team review

Collaborate with AVP
to develop smart phrase
that can be used to
efficiently place
education in the EHR
and on the after-visit
summary (AVS).

September
2022 to
April 2023

DNP Project
Team review
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Information
Technology
AVP

Appendix B
Organizational support from Virtua Health

Dear Kristin Pilong,
This letter is to inform you that you have organizational support from Virtua to conduct
your project entitled “Improving Medication education on an Infectious Disease Agent Unit
for Hospitalized Patients at Discharge: A Quality Improvement Project,” at Virtua. As the
Director of Professional Development and Nursing Research, I have the authority to
approve projects at Virtua. I have reviewed the purpose, aims, and methods of your
proposal, and I find that your quality improvement project is congruent with Virtua’s goals
and mission. Thank you for the opportunity to review your proposed project. As a quality
improvement project, it has been determined that this project is not research and does not
require IRB review. You may use observational data as no identifying information will be
collected. Participation in the education and observations will be voluntary and remain
anonymous. You have permission to collect, analyze, and report findings provided that
participant identification will be anonymous. Virtua reserves the right to withdraw
participation in the project if circumstances deem appropriate.
Sincerely,
Sue Politsky PhD, RN, NEA-BC
Director of Professional Development and Nursing Research Virtua Center for Learning
1200 Howard Blvd., Suite 100
Mt. Laurel, NJ 08054
(856)761-3804 (phone)
(856)761-3834 (fax)
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Appendix C
Inductive Qualitative Analysis on Teaching Process

Meaning Unit

Citation

Teach back used
as a tool for
understanding of
instruction.

Nickles et al. (2020)

Condensed
meaning unit
Description close to
the text
Improved
instruction

Centrella-Nigro and
Alexander (2017)

Condensed meaning unit
Interpretation of the
underlying meaning

Assessment of
patient’s
readiness to
learn

Ahrens and Wirges
(2013)
Lam et al. (2019)
Bartlett Ellis et al.
(2016)

Patient related factors
Lack of Knowledge

Patient centered
education

Nickles et al. (2020)

Health literacy
Accommodation of low
health literacy
Times of teaching needs
to be convenient for
patient not nursing
Information needs to be
reinforced and consistent

Prochnow et al.
(2019)

Technique and
method of
instruction is

Price (2019)
Gillam et al. (2016)

Theme

Information needs
reinforcement
Information must be
consistent

Prochnow et al.
(2019)
Assessment of
patient’s health
literacy.

Sub-theme

Improved
comprehension
with multimodal

Electronic availability of
education
57

Medication education

Poor communication

very important
for patient to
have a full
understanding of
medication
information

instruction.
Ahrens and Wirges
(2013)
Jones and Coke
(2016)

Variations in the
method of
instruction that is
effective for
patients.

Written instruction
Verbal instruction
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Variations in method of
instruction

Appendix D
Deductive and Inductive Content Analysis of Five Medications for the Cognitive Aid

Name of Medication

Why is the medication
prescribed

Citation

Adams and
Urban, 2019
Jones &
Bartlett
Learning
(2021)
Woo &
Robinson,
2020
Whalen et
al., 2019

Vancomycin
(Vancocin)

Piperacillin
and
tazobactam
(Zosyn)
Codes by Medications
Treatment and
Treatment of
prophylaxis of
infections such
susceptible
as urinary tract
bacterial infections infection and
other bacterial
To treat
infections.
pseudomembranous
colitis caused by
Clostridium
difficile (only oral
vancomycin)
Vancomycin is
bactericidal for
gram positive
organisms,
including
staphylococci,
streptococci,
pneumococci,
Corynebacterium,
Listeria,
Lactobacillus,
Actinomyces, and
Clostridium. It kills
59

Heparin
(subcutaneous)

Hydromorphone
hydrochloride
(Dilaudid)

Ceftriaxone
(Rocephin)

Prolongs
coagulation time,
thereby inhibiting
excessive clotting
within blood
vessels, prevents
the enlargement
of existing clots
and the formation
of new ones.
Inhibits the
action of the
coagulation
factors

To relieve pain
severe enough to
require opioid
treatment and for
which alternative
treatment options
such as nonopioid analgesics
or opioid
combination
products are
inadequate or not
tolerated
Relieves pain

To treat
infections
including skin
and soft tissue
infections,
gonorrhea,
syphilis, pelvic
inflammatory
disease,
epididymochitis,
gonococcal
conjunctivitis,
febrile
neutropenia

What does the medication
do

Adams and
Urban, 2019
Jones &
Bartlett
Learning,
2021
Woo &
Robinson,
2020
Whalen et
al., 2019

staphylococci
relatively slowly
and only if cells are
actively dividing.
Kills bacteria by
inhibiting bacterial
cell wall synthesis.
Inhibits bacterial
RNA and cell wall
synthesis; alters
permeability of
bacterial
membranes,
causing cell wall
lysis and cell death
Inhibits cell wall
synthesis by
binding firmly to
the D-A1a-D-A1a
terminus of nascent
peptidoglycan
pentapeptide. The
end result is a
weakened cell
susceptible to lysis.
The cell membrane
is also damaged,
contributing to the
antibacterial
effects.

Interferes with
the last step of
bacterial cell
wall synthesis,
which is the
cross-linking of
adjacent
peptidoglycan
strands by a
process known
as
transpeptidation.
The result is the
formation of a
weakened cell
wall and
ultimately cell
death.
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Activates the
enzyme
antithrombin III,
which in turns
inhibits thrombin

May bind with
opioid receptors
in the spinal cord
and higher levels
in the CNS. In
this way,
hydromorphone
is believed to
stimulate Kappa
and MU
receptors, thus
altering the
perception of an
emotional
response to pain
Relieves pain by
raising the pain
threshold at the
spinal cord level
and by altering
the brain’s
perception of
pain

Interferes with
bacterial cell wall
synthesis by
inhibiting
crosslinking of
peptidoglycan
strains.
Peptidoglycan
makes the cell
membrane rigid
and protective.
Without it,
bacterial cells
rupture and die

Patient teaching

Adams &
Urban, 2019
Jones &
Bartlett
Learning
2021
Woo &
Robinson,
2020
Whalen et
al., 2019

Notify the health
care provider
immediately of any
known or suspected
pregnancy,
maintain adequate
fluid intake (2-3
L/day)
Do not breast feed
while taking this
medication without
prior approval of
the health care
provider.

Anticoagulants
including heparin
and low
molecular weight
heparins may
significantly
increase the risk
of bleeding and
hemorrhage,
avoid smoking
and drinking
alcohol because
these may alter
the response of
heparin.
Do not take other
non-prescription
medications,
herbal
supplements, or
dietary
supplements
without approval
of the health care
provider.
Explain that
heparin cannot be
taken orally.
Inform patient
about increased
risk of bleeding;
urge patient to
avoid injuries and

Instruct patient to
use a calibrated
measuring device
to measure accurate
doses of oral
solution. Advise
patient to notify
prescriber if no
improvement
occurs after a few
days. Instruct
patient to complete
full course of
vancomycin, as
prescribed. Instruct
patient to notify
prescriber if
developing
61

Instruct patient to
take drug exactly
as prescribed and
before pain is
severe. Also tell
patient not to take
more drugs than
prescribed and
not to take it
longer than
absolutely
needed, because
excessive or
prolonged use
can lead to abuse,
addiction, misuse,
overdose, and
possibly death.
Alert patient that
drug is a
controlled
substance. Advise
patient to take
drug with food to
avoid GI distress.
Tell patient not to
break, chew,
crush, or dissolve
extended-release
tablets, but to
swallow them
whole. Inform
patient about fatal

Tell patient to
report evidence of
blood dyscrasia
super infection to
prescriber
immediately.
Urge patient to
report watery,
bloody stools to
prescriber
immediately,
even up to two
months after drug
therapy has
ended. Advise
patient to report
any
hypersensitivity
reactions, such as
a rash, itching
skin, or hives, to
prescriber
immediately and
to stop taking the
drug.

persistent or severe
diarrhea. Instruct
patient to keep
follow up
appointments
during and after
treatment.

to use a soft
bristled
toothbrush and an
electric razor.
urge patient to
report any
abnormal sign or
symptom 2
prescriber, even
weeks after
heparin has been
discontinued,
because of the
potential for
delayed adverse
reactions. Advise
patient to avoid
drugs that
interact with
heparin, such as
aspirin and
ibuprofen.
Instruct patient
and family to
watch for and
report abdominal
or lower back
pain, black
stools, bleeding
gums, bloody
urine, excessive
menstrual
bleeding,

The oral solution
can cause a bitter or
unpleasant taste
and mouth irritation
and should be
followed by a full
glass of water. Oral
vancomycin can be
taken without
regard to meals. If
not able to take by
mouth, oral
vancomycin can be
administered by
nasogastric tube,
enema, long
intestinal tube, or
directly into
colostomy or
ileostomy

62

addictive effects
of combining
hydromorphone
with
benzodiazepine.
In addition, other
serious drug
reactions can
occur. Instruct
patient to inform
all prescribers of
hydromorphone
use. Caution
patient to avoid
alcohol and over
the counter drugs
during therapy,
and less
prescriber
approves. Instruct
patient to report
Constipation,
difficulty
breathing, severe
nausea, or
vomiting. Inform
patient that drug
may cause
drowsiness and
sedation. Advise
patient to avoid
hazardous
activities and troll

nosebleeds, and
severe headaches.
Also tell patient
to report any
persistent, severe,
or unusual signs
and symptoms to
prescriber
immediately.
Alert patient
receiving heparin
subcutaneously
that necrosis of
the skin has been
reported
following
subcutaneous
administration of
heparin. Explain
that temporary
hair loss may
occur. Advise
patient to wear or
carry appropriate
medical
identification.
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medications CNS
effects are
known. Tell
patient to change
position slowly to
minimize
orthostatic
hypotension.
Instruct
physically
dependent patient
not to stop taking
hydromorphone
abruptly to avoid
withdrawal. Warn
patient to keep
medication out of
the reach of
children, as
accidental
ingestion may
cause death.
Advise women of
childbearing age
to notify
prescriber
immediately if
they suspect they
are pregnant or
become pregnant
because
hydromorphone
may cause fetal

harm or neonatal
withdrawal that
could be life
threatening.
Advise patients
when
hydromorphone
tablets or solution
are no longer
needed to remit to
authorities at a
certified drug
take back
program. Inform
patients that long
term use of
opioids like
hydromorphone
may decrease sex
hormone levels,
causing decreased
libido, erectile
dysfunction,
impotence,
infertility, or lack
of menstruation.
Interactions:
Drugs

Adams &
Urban, 2019
Jones &
Bartlett

Adds to toxicity of
aminoglycosides,
Bumetanide,
amphotericin B,
cisplatin,
cyclosporine,

When combined
with
vancomycin,
leads to higherthan-expected
rates of
64

Oral
anticoagulants,
including
warfarin,
potentiate
heparin activity.

Medications that
affect the
serotonin
neurotransmitter
system linezolid,
methylene blue,

Learning,
2021)
Woo &
Robinson,
2020
Whalen et
al., 2019

polymyxin B, and
other ototoxic and
nephrotoxic
medications. May
also increase the
risk of lactic
acidosis when
administered with
metformin,
especially in
patients with renal
impairment.
Drugs that also
have nephrotoxic
effects
(aminoglycosides,
piperacillintazobactam,
furosemide). The
concomitant
administration
increases the risk
and should be
avoided if possible.

nephrotoxicity
and this
combination
should be used
with caution,
potassium
wasting
diuretics may
have increased
risk for
hypokalemia;
the reverse is
true for
potassiumsparing
diuretics.
Increased levels
of methotrexate
if taken
together.
The efficacy of
oral
contraceptives
may be reduced
and increased
breakthrough
bleeding may
occur. Although
infrequently
reported,
contraceptive
failure is
possible.
65

Drugs that inhibit
platelet
aggregation such
as aspirin
indomethacin and
ibuprofen may
induce bleeding.
Nicotine,
digoxin,
tetracyclines, or
antihistamines
may inhibit
anticoagulation.

selective
serotonin
reuptake
inhibitors,
serotonin and
neuro epinephrine
reuptake
inhibitors,
tricyclic
antidepressants
can increase risk
of serotonin
syndrome.
Anticholinergics:
increased risk of
ileus, severe
Constipation, or
urine retention.
Antipsychotics,
benzodiazepine,
and other CNS
depressions:
increased risk of
coma,
hypertension,
profound
sedation, and
severe respiratory
depression.
Diuretics:
reduced effects of
diuretics. Mixed
agonist

Delays in renal
elimination if
taken with
Probenecid.
Bacteriostatic
action of
tetracyclines
may impair
bactericidal
effects of
penicillin.
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antagonist, partial
agonist opioid
analgesics such
as buprenorphine,
butorphanol,
nalbuphine,
pentazocine:
Possibly reduced
analgesic effect
of
hydromorphone;
May precipitate
withdrawal
symptoms.
Monoamine
oxidase inhibitors
(MaOIs):
increased risk of
serotonin
toxicity;
Increased risk of
opioid toxicity.
Muscle relaxants:
possibly
enhanced
neuromuscular
blocking action
of skeletal muscle
relaxants
producing
increased degree
of respiratory
depression.

Food

Adams and
Urban, 2019

Herbal
supplements that
may affect
coagulation such
as ginger, garlic,
green tea,
feverfew, or
ginkgo should be
avoided because
they may
increase the risk
of bleeding

Jones &
Bartlett
Learning,
2021
Woo &
Robinson,
2020
Whalen et
al., 2019
Adverse Reactions:
CNS

Adams &
Urban, 2019
Jones &
Bartlett
Learning,
2021
Woo &
Robinson,
2020
Whalen et
al., 2019

Fever, chills,
confusion, seizures,
hallucinations,
Depression fatigue
Vertigo insomnia
headache

Neurotoxicity
(penicillins are
irritating to
neuronal tissue
and can provoke
seizures if
injected
intrathecally or
if very high
blood levels,
epileptic
patients are
particularly at
risk due to the
ability of
penicillin to
cause
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fever, chills,
Dizziness,
headache,
peripheral
neuropathy

Anxiety, CNS
depression,
confusion,
dizziness,
drowsiness,
euphoria,
hallucinations,
headache,
nervousness,
restlessness,
sedation,
somnolence,
tremor, weakness.

Fatigue, Chills,
fever, headache,
hypertonia,
seizures.

GABAergic
inhibition.
CV

Adams &
Urban, 2019
Jones &
Bartlett
Learning.
2021

Flushing,
hypotension,
tachycardia,
peripheral edema,
vasculitis.

chest pain,
rebound
hyperlipidemia,
thrombosis

Hypertension,
orthostatic
hypotension,
palpitations,
tachycardia

Edema

Tinnitus, high tone
hearing loss

nosebleeds,
gingival
bleeding, rhinitis.

Blurred vision,
diplopia, dry
mouth, laryngeal
edema, laryngeal
spasms,
nystagmus,
tinnitus.

hearing loss

Nausea, Abdominal Diarrhea caused
pain, Constipation, by a disruption
of the normal

abdominal
distention and
pain, elevated

Abdominal
cramps, anorexia,
biliary tract

diarrhea
abdominal
cramping nausea,

Woo &
Robinson,
2020

EENT

Whalen et
al., 2019
Adams and
Urban, 2019
Jones &
Bartlett
Learning,
2021
Woo &
Robinson,
2020

GI

Whalen et
al., 2019
Adams &
Urban, 2019
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Jones &
Bartlett
Learning,
2021

C diff , flatulence,
vomiting

Woo &
Robinson,
2020)

GU

Whalen et
al., 2019)
Adams &
Urban, 2019
Jones &
Bartlett
Learning,
2021

balance of
liver enzymes,
intestinal
hematemesis,
microorganisms. melena, nausea,
retroperitoneal
hemorrhage,
vomiting

Nephrotoxicity
(increased serum
creatinine and
BUN) acute kidney
injury, UTI,
interstitial
nephritis.

hematuria, hyper
menorrhea,
ovarian
hemorrhage,
priapism

Anemia, reversible
neutropenia,
eosinophilia, and
thrombocytopenia.

Abnormal
bleeding is
common with
heparin therapy
occurring in
about 10% of
patients bleeding
may be major or

spasm,
Constipation,
hepatotoxicity,
nausea, vomiting.

C diff associated
diarrhea,
diarrhea, elevated
liver enzymes,
gallbladder
dysfunction,
hepatic failure,
hepatitis,
hepatomegaly,
oral candidiasis.

Decreased libido,
erectile
dysfunction,
impotence,
infertility, lack of
menstruation,
urine retention.

vaginal
Candidiasis, New
renal failure,
elevated BUN
level,
nephrotoxicity,
oliguria,

Woo &
Robinson,
2020)

HEME

Whalen et
al., 2019)
Adams &
Urban, 2019
Jones &
Bartlett
Learning,
2021
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agranulocytosis, a
plastic anemia,
leukopenia
neutropenia and
thrombocytopenia

Woo &
Robinson,
2020

minor, and may
involve any
system in the
body, Easy
bruising,
excessive
bleeding from
wounds.
Osteoporosis has
been reported in
patients taking
the medication
longer than 30
days, Back pain,
myalgia.

Whalen et
al., 2019)

MS

Adams &
Urban, 2019

Back pain

Jones &
Bartlett
Learning,
2021
Woo &
Robinson,
2020)

RESP

Whalen et
al., 2019
Adams and
Urban, 2019

dyspnea, wheezing

asthma, dyspnea,
wheezing

Jones &
Bartlett
Learning,
2021
Woo &
Robinson,
2020)
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arthralgia

Dyspnea,
respiratory
depression
(especially in
obstructive sleep
apnea,
emphysema, or
cor pulmonale),
wheezing

allergic
pneumonitis,
dyspnea

SKIN

Whalen et
al., 2019
Adams &
Urban, 2019
Jones &
Bartlett
Learning,
2021
Woo &
Robinson,
2020

OTHER

Whalen et
al., 2019
Adams &
Urban, 2019
Jones &
Bartlett
Learning,
2021

Rash on the upper
body, a condition
called the red man
syndrome,
exfoliative
dermatitis
thrombophlebitis,
pruritis, toxic
epidermal necro
lysis

skin rashes,
exfoliative
dermatitis,
blood
dyscrasias.

Urticaria, skin
lesions may
develop
especially at the
site of parenteral
injections,
alopecia,
petechiae,
pruritis.

diaphoresis,
flushing

rash pruritis,
allergic
dermatitis,
ecchymosis,
erythema,
Stevens-Johnson
syndrome, toxic
epidermal
necrolysis.

Anaphylaxis, drug
induced fever,
hypokalemia, super
infection

prolonged or
repeat use may
result in
bacterial or
fungal
overgrowth also
known as a
super infection.

Anaphylaxis;
heparin
resistance;
histamine like
reactions at
injection site,
including
necrosis of the
skin;
hypersensitivity
reactions,
subcutaneous
deep injection
site hematoma,
irritation, pain,
redness, and
ulceration.

physical and
psychological
dependence

oral candidiasis,
Anaphylaxis;
Drug fever;
Injection site
redness, redness,
and swelling;
Serum sickness;
Super infection

Woo &
Robinson,
2020
Whalen et
al., 2019
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Appendix E
Cognitive Aid Drafts

Ceftriaxone (Rocephin) Flesch Kincaid Reading Level = 5.3
Please use this sheet to help you to know facts about your medications. It adds
to instructions from your healthcare provider and nurse. You may or may not go
home on these medications.
What is this medication used for?
• It treats bacterial infections.
How does this medication work?
• Ceftriaxone works to kill the bacteria and fight the infection.
How is this medication best taken?
• It is given as a solution in your vein through your IV.
Are there any safety points about this medication?
• Tell your healthcare provider
o The names of all medications you are currently taking. This
medication may not mix well with other medications.
o If you are pregnant or plan to get pregnant.
o If you are breast-feeding.
o If you have gallbladder disease.
o If you have kidney disease.
• Avoid beer, wine, or mixed drinks.
What are some side effects of this medication?
• Irritation at the IV site.
• Fatigue.
• Fever.
• Nausea, vomiting, diarrhea.
• Thrush (fungal infection in the mouth).
• For women, vaginal yeast infection. Report itching or discharge.
• Rash.
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When do I need to call my healthcare provider?
• Signs of a very bad reaction to the medication: wheezing; chest tightness;
fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips,
tongue, or throat.
• Very bad belly pain or throwing up.
• Very loose stools (diarrhea), even after medication is stopped.
• Any rash.

References:
Adams, M., & Urban, C. Q. (2019). Pharmacology: Connections to nursing practice (4th ed.). Pearson.
Jones & Bartlett Learning. (2021). Nurse’s Drug Handbook. Twentieth Edition.
Whalen, K. (2019). Lippincott Illustrated Reviews Pharmacology. (C.Field & R. Radhakrishnan, EDS.) (Seventh). Wolters Kluwer
Woo, T. M., & Robinson, M. V. (2020). Pharmacotherapeutics for Advanced Practice Nurse Prescribers (Fifth). F.A. Davis Company.
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Vancomycin (Vancocin) Flesch Kincaid Reading Level = 6.0
Please use this sheet to help you to know facts about your medications. It adds
to instructions from your healthcare provider and nurse. You may or may not go
home on these medications.
What is this medication used for?
It stops or treats bacterial infections. Oral vancomycin treats clostridium
difficile (C. diff.)
How does this medication work?
Vancomycin works to kill the bacteria and fight infection.
How is this medication best taken?
Intravenous (IV)
• It is given as a solution in your vein through your IV.
Oral (liquid):
• Take with or without food.
• Those with feeding tubes may also use the liquid. Flush the feeding tube
before and after this drug is given.
Are there any precautions when using this medication?
• Tell your healthcare provider:
o The names of all medications you are currently taking. This
medication may not mix well with other medications.
o If you are pregnant or plan to get pregnant.
o If you are breast-feeding.
• May increase the risk of lactic acidosis when administered with metformin,
especially in patients with KIDNEY PROBLEMS.
• Medications that also affect kidneys: aminoglycosides, piperacillintazobactam, and furosemide should be avoided if possible.
• Irritation of the vein or IV site if given through IV.
What are some side effects of this medication?
• Flushing.
• Low blood pressure.
• Fast heart rate.
• Headache.
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• Hearing loss.
• Nausea, vomiting, diarrhea, or belly pain
• Stomach pain.
• Clostridium difficile (C. diff.)
• Urinary tract infection.
• Acute kidney injury.
• Rash on upper body.
• Anemia.
When do I need to call my healthcare provider?
• Signs of a very bad reaction to the drug: wheezing; chest tightness; fever;
itching; bad cough; blue skin color; seizures; or swelling of face, lips,
tongue, or throat.
• Very loose stools (diarrhea), even after doses are complete.
• Very bad skin irritation.
• During the IV infusion, a rash on the face, neck, trunk, and arms.
• Big change in balance.
• Notify healthcare provider if no improvement occurs after a few days.
• Ringing in ears or change in hearing.
• Cannot urinate.

References:
Adams, M., & Urban, C. Q. (2019). Pharmacology: Connections to nursing practice (4th ed.). Pearson.
Jones & Bartlett Learning. (2021). Nurse’s Drug Handbook. Twentieth Edition.
Whalen, K. (2019). Lippincott Illustrated Reviews Pharmacology. (C.Field & R. Radhakrishnan, EDS.) (Seventh). Wolters Kluwer
Woo, T. M., & Robinson, M. V. (2020). Pharmacotherapeutics for Advanced Practice Nurse Prescribers (Fifth). F.A. Davis Company.
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Piperacillin/Tazobactam (Zosyn) Flesch Kincaid Reading
Level=5.9
Please use this sheet to help you to know facts about your medications. It adds
to instructions from your healthcare provider and nurse. You may or may not go
home on these medications.
What is this medication used for?
• It treats bacterial infections.
How does this medication work?
• Piperacillin works to harm bacteria and fight infection.
• Tazobactam sodium protects piperacillin from being wiped out by some
types of bacteria.
How is this medication best taken?
• It is given as a solution in your vein through your IV.
Are there any precautions when using this medication?
• Tell your healthcare provider:
o The names of all medications you are currently taking. This
medication may not mix well with other medications.
o If you have kidney disease.
o If you are pregnant or plan to get pregnant.
o If you are breast feeding.
• Avoid beer, wine, or mixed drinks.
• If you are taking a potassium wasting diuretic, you may have an increased
risk of low potassium.
• If you are taking a potassium sparing diuretic, you may have an increased
risk for high potassium.
• Effectiveness of oral contraceptive drugs may be reduced.
What are some side effects of this medication?
• Nausea, vomiting, diarrhea, or belly pain
• Headache.
• For women, vaginal yeast infection. Report itching or discharge.
When do I need to call my healthcare provider?
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•

•
•
•

Signs of a very bad reaction to the drug: wheezing; chest tightness; fever;
itching; bad cough; blue skin color; seizures; or swelling of face, lips,
tongue, or throat.
Very bad belly pain or throwing up.
Very loose stools (diarrhea), even after medication is stopped.
Any rash.

References:
Adams, M., & Urban, C. Q. (2019). Pharmacology: Connections to nursing practice (4th ed.). Pearson.
Jones & Bartlett Learning. (2021). Nurse’s Drug Handbook. Twentieth Edition.
Whalen, K. (2019). Lippincott Illustrated Reviews Pharmacology. (C.Field & R. Radhakrishnan, EDS.) (Seventh). Wolters Kluwer
Woo, T. M., & Robinson, M. V. (2020). Pharmacotherapeutics for Advanced Practice Nurse Prescribers (Fifth). F.A. Davis Company.
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Hydromorphone (Dilaudid)(Flesch Kincaid Reading Level = 6.2)
Please use this sheet to help you to know facts about your medications. It adds
to instructions from your healthcare provider and nurse. You may or may not go
home on these medications.
What is this medication used for?
• It is used to ease or relieve pain.
How does this medication work?
• Hydromorphone decreases the feeling of pain and how people react to
pain.
How is this medication best taken?
By mouth or through an IV.
Are there any safety points about using this medication?
• Talk with your healthcare provider:
o If you have been taking this medication for many weeks, you may
want to slowly stop this medication.
o If you have a history of a medication or drinking problem.
o If you are taking a selective serotonin reuptake inhibitor (SSRI) or a
tricyclic antidepressant, it may increase risk of serotonin syndrome.
o If you have seizures.
o If you have liver disease.
o Talk about all medications you are taking with your healthcare
provider. This medication may not mix well with some other
medications.
• This medication may be habit-forming with long-term use.
• Take medication exactly as prescribed.
• Take with or without food. Take with food if it causes an upset stomach.
• Those who have feeding tubes may also use the liquid form. Flush the
feeding tube before and after taking this medication.
• Long-acting products: Swallow whole. Do not chew, break, or crush.
• Do not use long-acting products for fast pain relief or as needed.
• Avoid beer, wine, mixed drinks, or other medications and natural products
that decrease your ability to react.
• Tell your healthcare provider if you are pregnant or plan on getting
pregnant.
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What are some side effects of this medication?
• Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking
clearly. Avoid driving and doing other tasks or actions that call for you to be
alert or have clear eyesight until you see how this medication affects you.
• May cause a decrease in blood pressure, palpitations, fast heartbeat.
• Feeling dizzy: rise slowly over a few minutes when sitting or lying down. Be
careful climbing.
• Upset stomach or throwing up; diarrhea.
• Hard stools (constipation). Drinking more liquids, working out, or adding
fiber to your diet may help. Talk with your healthcare provider about a
stool softener or laxative.
When do I need to call my healthcare provider?
• If you think you had an overdose, call your local poison control center or
Emergency Room right away.
• Signs of a very bad reaction to the medication: wheezing; chest tightness;
fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips,
tongue, or throat.

References:
Adams, M., & Urban, C. Q. (2019). Pharmacology: Connections to nursing practice (4th ed.). Pearson.
Jones & Bartlett Learning. (2021). Nurse’s Drug Handbook. Twentieth Edition.
Whalen, K. (2019). Lippincott Illustrated Reviews Pharmacology. (C.Field & R. Radhakrishnan, EDS.) (Seventh). Wolters Kluwer
Woo, T. M., & Robinson, M. V. (2020). Pharmacotherapeutics for Advanced Practice Nurse Prescribers (Fifth). F.A. Davis Company.
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h

Heparin (subcutaneous) Flesch Kincaid Reading Level = 5.2
Please use this sheet to help you to know facts about your medications. It adds
to instructions from your physician and nurse. You may or may not go home on
these medications.
What is this medication used for?
• It thins the blood so that clots will not form.
How does this medication work?
• Heparin changes the body's clotting system. It thins the blood to stop clots
from forming.
How is this medication best taken?
• It is injected into the skin, usually around the area of the belly button.
• Wash your hands before and after use.
• Rotate between the sites where you give the injection.
• Throw away needles in a needle/sharp disposal box and take the box back
to your healthcare provider when it is full.
Are there any safety points about using or taking this medication?
• Talk with your healthcare provider before using products that have aspirin,
blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain
medications, or vitamin E.
• Tell dentists, surgeons, and other healthcare providers that you are taking
this medication.
• You may bleed more easily. Be careful and avoid injury. Use a soft
toothbrush and an electric razor.
• Be careful to stop injuries and avoid falls or crashes.
• Tell your healthcare provider if you are pregnant or plan on getting
pregnant.
• Tell your healthcare provider if you are breast-feeding.
What are some side effects of this medication?
• Bleeding problems.
• Irritation where the injection is given.
• May cause weak bones with long-term use.
When do I need to call my healthcare provider?
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•

•
•
•

Signs of a very bad reaction to the medication: wheezing; chest tightness;
fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips,
tongue, or throat.
A fall or crash when you hit your head. Talk with your healthcare provider
even if you feel fine.
Swelling or pain in the leg or arm.
Any rash.

References:
Adams, M., & Urban, C. Q. (2019). Pharmacology: Connections to nursing practice (4th ed.). Pearson.
Jones & Bartlett Learning. (2021). Nurse’s Drug Handbook. Twentieth Edition.
Whalen, K. (2019). Lippincott Illustrated Reviews Pharmacology. (C.Field & R. Radhakrishnan, EDS.) (Seventh). Wolters Kluwer
Woo, T. M., & Robinson, M. V. (2020). Pharmacotherapeutics for Advanced Practice Nurse Prescribers (Fifth). F.A. Davis Company.
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Appendix F
Expert Content Validity Form for Five Cognitive Aids

Directions:
Conceptual Definition:
Components

Expert Content Validity Check
Content Experts: Please critique the conceptual definition of framework. Type suggestions in the
space provided. Please add comments
Content Experts: Please critique all items. Please read each item and rank the item using the scale
provided.
Use yellow highlighting to select the number on the scale. Kindly comment as you evaluate each
item.
Save the document and the completed document email to pilongk1@lasalle.edu.
You may prefer circling your responses on the 4-point scale provided. Then scan and send the pdf
of the document to pilongk1@lasalle.edu
Thank you very much.

Vancomycin
1. Directions on the cognitive aid
include a bulleted description of
how to deliver the teach back
method.
2. The cognitive aid lists the
evidence-based literature that
informed the content of the aid.
3. The cognitive aid identifies at
least two names of the
medication.
4. The cognitive aid describes how
the medication works to treat a
health problem.
5. The cognitive aid describes why
the medication was prescribed.

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment.

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

82

6. The dosage of the medication is
clearly identified on the
cognitive aid.
7. The route of administration of
the medication is clearly
identified on the cognitive aid.
8. The cognitive aid describes the
medication’s side effects.
9. The cognitive aid describes the
adverse reactions of the
medication.
10. The cognitive aid addresses
pertinent patient teaching.
11. The cognitive aid is written at a
6th grade level or below.
12. The print size and format of the
cognitive aid makes it easy to
use.
13. The cognitive aid provides
information that promotes
patient safety.

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant
2 = somewhat
relevant

3 = quite
relevant
3 = quite
relevant

4 = highly
relevant
4 = highly
relevant

Comment

2 = somewhat
relevant
2 = somewhat
relevant
2 = somewhat
relevant

3 = quite
relevant
3 = quite
relevant
3 = quite
relevant

4 = highly
relevant
4 = highly
relevant
4 = highly
relevant

Comment

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

1 = not relevant
1 = not relevant
1 = not relevant

1 = not relevant

Comment

Comment
Comment

Piperacillin and tazobactam
1. Directions on the cognitive aid 1 = not relevant
include a bulleted description of
how to deliver the teach back
method.
2. The cognitive aid lists the
1 = not relevant
evidence-based literature that
informed the content of the aid.
3. The cognitive aid identifies at
1 = not relevant
least two names of the
medication.

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment
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4. The cognitive aid describes how
the medication works to treat a
health problem.
5. The cognitive aid describes why
the medication was prescribed.
6. The dosage of the medication is
clearly identified on the
cognitive aid.
7. The route of administration of
the medication is clearly
identified on the cognitive aid.
8. The cognitive aid describes the
medication’s side effects.
9. The cognitive aid describes the
adverse reactions of the
medication.
10. The cognitive aid addresses
pertinent patient teaching.
11. The cognitive aid is written at a
6th grade level or below.
12. The print size and format of the
cognitive aid makes it easy to
use.
13. The cognitive aid provides
information that promotes
patient safety.

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant
2 = somewhat
relevant

3 = quite
relevant
3 = quite
relevant

4 = highly
relevant
4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant
2 = somewhat
relevant

3 = quite
relevant
3 = quite
relevant

4 = highly
relevant
4 = highly
relevant

Comment

2 = somewhat
relevant
2 = somewhat
relevant
2 = somewhat
relevant

3 = quite
relevant
3 = quite
relevant
3 = quite
relevant

4 = highly
relevant
4 = highly
relevant
4 = highly
relevant

Comment

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

1 = not relevant

1 = not relevant
1 = not relevant
1 = not relevant

1 = not relevant

Comment

Comment

Comment
Comment

Heparin
1. Directions on the cognitive aid
1 = not relevant
include a bulleted description of
how to deliver the teach back
method.

2 = somewhat
relevant
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2. The cognitive aid lists the
evidence-based literature that
informed the content of the aid.
3. The cognitive aid identifies at
least two names of the
medication.
4. The cognitive aid describes how
the medication works to treat a
health problem.
5. The cognitive aid describes why
the medication was prescribed.
6. The dosage of the medication is
clearly identified on the
cognitive aid.
7. The route of administration of
the medication is clearly
identified on the cognitive aid.
8. The cognitive aid describes the
medication’s side effects.
9. The cognitive aid describes the
adverse reactions of the
medication.
10. The cognitive aid addresses
pertinent patient teaching.
11. The cognitive aid is written at a
6th grade level or below.
12. The print size and format of the
cognitive aid makes it easy to
use.
13. The cognitive aid provides
information that promotes
patient safety.

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant
2 = somewhat
relevant

3 = quite
relevant
3 = quite
relevant

4 = highly
relevant
4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant
2 = somewhat
relevant

3 = quite
relevant
3 = quite
relevant

4 = highly
relevant
4 = highly
relevant

Comment

2 = somewhat
relevant
2 = somewhat
relevant
2 = somewhat
relevant

3 = quite
relevant
3 = quite
relevant
3 = quite
relevant

4 = highly
relevant
4 = highly
relevant
4 = highly
relevant

Comment

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

1 = not relevant

1 = not relevant
1 = not relevant
1 = not relevant

1 = not relevant

Hydromorphone hydrochloride
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Comment

Comment

Comment
Comment

1. Directions on the cognitive aid
include a bulleted description of
how to deliver the teach back
method.
2. The cognitive aid lists the
evidence-based literature that
informed the content of the aid.
3. The cognitive aid identifies at
least two names of the
medication.
4. The cognitive aid describes how
the medication works to treat a
health problem.
5. The cognitive aid describes why
the medication was prescribed.
6. The dosage of the medication is
clearly identified on the
cognitive aid.
7. The route of administration of
the medication is clearly
identified on the cognitive aid.
8. The cognitive aid describes the
medication’s side effects.
9. The cognitive aid describes the
adverse reactions of the
medication.
10. The cognitive aid addresses
pertinent patient teaching.
11. The cognitive aid is written at a
6th grade level or below.
12. The print size and format of the
cognitive aid makes it easy to
use.

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant
2 = somewhat
relevant

3 = quite
relevant
3 = quite
relevant

4 = highly
relevant
4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant
2 = somewhat
relevant

3 = quite
relevant
3 = quite
relevant

4 = highly
relevant
4 = highly
relevant

Comment

2 = somewhat
relevant
2 = somewhat
relevant
2 = somewhat
relevant

3 = quite
relevant
3 = quite
relevant
3 = quite
relevant

4 = highly
relevant
4 = highly
relevant
4 = highly
relevant

Comment

1 = not relevant

1 = not relevant

1 = not relevant
1 = not relevant
1 = not relevant
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Comment

Comment

Comment
Comment

13. The cognitive aid provides
information that promotes
patient safety.

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

Ceftriaxone
1. Directions on the cognitive aid
include a bulleted description of
how to deliver the teach back
method.
2. The cognitive aid lists the
evidence-based literature that
informed the content of the aid.
3. The cognitive aid identifies at
least two names of the
medication.
4. The cognitive aid describes how
the medication works to treat a
health problem.
5. The cognitive aid describes why
the medication was prescribed.
6. The dosage of the medication is
clearly identified on the
cognitive aid.
7. The route of administration of
the medication is clearly
identified on the cognitive aid.
8. The cognitive aid describes the
medication’s side effects.
9. The cognitive aid describes the
adverse reactions of the
medication.
10. The cognitive aid addresses
pertinent patient teaching.

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant
2 = somewhat
relevant

3 = quite
relevant
3 = quite
relevant

4 = highly
relevant
4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

2 = somewhat
relevant
2 = somewhat
relevant

3 = quite
relevant
3 = quite
relevant

4 = highly
relevant
4 = highly
relevant

Comment

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment

1 = not relevant

1 = not relevant

1 = not relevant
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Comment

Comment

11. The cognitive aid is written at a
6th grade level or below.
12. The print size and format of the
cognitive aid makes it easy to
use.
13. The cognitive aid provides
information that promotes
patient safety.

1 = not relevant
1 = not relevant

1 = not relevant

2 = somewhat
relevant
2 = somewhat
relevant

3 = quite
relevant
3 = quite
relevant

4 = highly
relevant
4 = highly
relevant

Comment

2 = somewhat
relevant

3 = quite
relevant

4 = highly
relevant

Comment
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Comment

Appendix G
Script for Email Message to Content Experts
Dear XXX:
I am carrying out my Doctor of Nursing Practice project and inviting you to help me with
accomplishing this part of my doctoral education.
I am interested in identifying key elements of cognitive aids for high frequency
prescribed medications to address a gap in practice related to nurse communication about
medications.
You have been identified as an expert on medication education with extensive clinical
experience on anesthesia care and/or medication knowledge. Please participate in our quality
improvement project as an expert by judging the content part of cognitive aid. The content is
based on a literature review on the topic of medication shortages as affecting anesthesia care.
I have consulted with a hospital-based Institutional Review Board, and I do not need
human subjects’ permission for this expert validation phase of my quality improvement project.
However, your identity will not be revealed. I will identify you as an expert and describe your
expertise only.
Please select the ranks on the 4-point scale first and enter comments on any additions or
revisions you think are important for the content of the cognitive aid.
Highlight your selected ranks on each content area included on the form by using
highlighting. Then save your responses and email the document to pilongk1@lasalle.edu.
Please select the ranks on the 4-point scale next and enter comments on any additions or
revisions you think are important for the content of the teaching plan.
I am asking that you will complete this and return to me within three weeks. Thank you.
Kristin Pilong, MSN, RN, CNL, Doctoral Student
Zane Robinson Wolf, PhD, RN, CNE, ANEF, FAAN, Project Team Chair
Kristen Overbaugh, PhD, RN, ACNS-BC, CHPN, Project Team Faculty
Kimberly Edson, DNP, RN Preceptor on Project Tea
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Appendix H
Comments from Content Experts with Revision Decisions
Type of Comments and Comments
Revision Decisions
General Comments about all Cognitive Aids
Tools are simple and easy to read
Teach Back diagram
Moved the teach back to the top
of the cognitive aid and removed
• Teach back diagram should be an attachment to the
the diagram
medication document, not directly on the document.
• Chart lacks direction and focus on teach back, should
be at the top in order to set the expectation for teach
back
• It is confusing in that if using as a tool for nursing to
instruct the patient then the teach back method should
be placed on top where the patient’s directions are.
Patients do not need this.
Reviewers would like to see a notation that gives direction Added Reputable websites that
to patient on where to find additional information.
end in .org or .gov
(https://druginfo.nlm.nih.gov
mayoclinic.org)
Medication category/pharmacological class should be
included; often time’s patients know whether they are
allergic to a category of medication.
Need to trademark the trade name.
Location on the sheet for RN to insert patient’s diagnosis
or infection.
Dosage not listed, only needed if patient is going home on
medication / Dosage for antibiotics not relevant but
important for pain medications / Difficult to do on the
sheet since patient different dose dependent on various
factors of infection.
All medication sheets should have a place to document if
they have an allergy to medication.
All antibiotics to take as directed for as long as provider
says even if feeling better to make sure infection is fully
destroyed.
Recommendation to have separate sheets for different
dosage forms (oral vs injection, SQ vs infusion).
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Added next to the name of
medication.
Added for all trade name
medications
Added under the name of the
medication
Added under the name of the
medication.

Did not add, not necessary for
the cognitive aid.
Added to the cognitive aid

Proceeded with
recommendation, additional
sheets should be created,

removed information about other
forms of the medication.
Reviewed and added trade or
generic names as needed.

Should use trade and generic names for any medication
listed on the sheet, example: metformin is used on
vancomycin sheet, should have both names listed.
Specific Comments about Individual Cognitive Aids by Medication
Vancomycin
Recommendation to list oral vancomycin on a different
Oral vancomycin information
sheet since the IV cannot penetrate the colon, could be
was removed, will create a sheet
confusing to patient.
specifically for oral vancomycin
Why the medication is prescribed:
in the future.
Add the medication may be used to treat MRSA.
Did not add MRSA due to the
fact that did not list any other
• Consider rewording such as it helps to eliminate
specific infections.
bacterial infections
• Describes why generally, but not specifically.
• Important to tell patient why they are taking even if not
saying specific infection
Changed lactic acidosis to lactic
• change lactic acidosis to something easier for the
acid build up.
patient to understand
The cognitive aid was not meant
• Side effects are noted, but list not exhaustive
to list all side effects.
Re-word this list so there is a better flow. For instance, the Revised so there was no
header reads- when do I need to call my HCP? So, your
duplication of calling health care
answers should flow from there. Restate that you should
provider
notify HCP if no improvement.
Missing elements of safety. Can cause balance issues but
This information was not found
there is no directions to call for assistance before getting
when performing the qualitative
OOB, etc.
analysis.
When calling healthcare provider for diarrhea insert
Inserted
uncontrollable since most people do get some sort of
diarrhea..
Oral and IV vancomycin should be listed on separate
Removed oral vancomycin from
sheets.
the cognitive aid.
Piperacillin and Tazobactam
Necessary but poorly executed in the wording. Suggested
Recommendation taken and
“Piperacillin and tazobactam work together like partners.
wording changed.
The piperacillin kills the bacteria. The tazobactam protects
the piperacillin so that it can work to fight the bacteria.”
Consider changing the second statement as “wiped-out” is Wiped out removed.
considered slang.
Reword potassium-sparing sentence or provide an example Reworded
“your potassium may be too high or too low if you take a
diuretic medication. Be sure to check with your provider
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first.” Change oral contraceptive line to something more
easily understood, example: Birth control may not work as
well, so make sure you use other types of protection.”
Heparin
Bleeding problems vague.
Would suggest re-wording “crash.”
Important to teach patient injection technique, consider
adding a few others.
Some patient teaching points are missing such as wear a
medical alert bracelet if long term, seat belt, etc.
Hydromorphone hydrochloride
May consider acute and chronic pain management (may
what to add that to the description of why the med is
described as used short term for acute pain.
Only listed as by mouth or IV yet indicate that it can be
given through peg tube.

Removed the word “crash”
The cognitive aid was not meant
to include everything for the
patient during the stay.
The cognitive aid was not meant
to include everything for the
patient during the stay.

The cognitive aid was not meant
to include everything for the
patient during the stay.
Removed oral administration
based on previous
recommendations for other
medications
Change call poison control and ED to call poison control or Changed
go to an emergency department. Reads like the patient
should call the ED, which in an overdose situation we
would not want them to do.
Opportunity to lower below 6 with removing some extra
Removed unnecessary words
words and rewording some of the sentences.
recommendation to eliminate unnecessary words and
phrases so that the patient can obtain the important pieces.
Recommend breaking up short and long acting. The long
Removed oral form of
acting gets lost in the bullets, but important for the patient
hydromorphone hydrochloride
to know to not crush or chew.
from this cognitive aid, should
have its own.
Consider bolding Do NOT chew, break, or crush.
Removed
Ceftriaxone
Consider including increase water intake if not
This was not consistent with the
contraindicated.
analysis performed.
Provider needs to know all patient allergies, many patients Added to the cognitive aid.
who are allergic to penicillin are also allergic to
cephalosporin.
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Appendix I
Cognitive Aids after Revisions
TEACH-BACK APPROACH FOR CLINICIAN
1.Use simple terms to explain or demonstrate 2. Check understanding.: Ask the patient to repeat back in their own
words. 3. Clarify: Identify and re-explain any misunderstandings. 4. Re-check and re-clarify: Repeat steps 2-3 until
no misunderstandings. 5. Close the loop. Once all misunderstandings are clarified, ask the patient to repeat
everything in their own words.

Ceftriaxone (Rocephin™) Cephalosporin
Dosage:
Diagnosis:
• Please use this sheet to help you to know facts about your medications. It adds to
instructions from your healthcare provider and nurse. You may or may not go
home on this medication.
What is this medication used for?
• It treats bacterial infections.
How does this medication work?
• Ceftriaxone works to kill the bacteria and fight the infection.
How is this medication best taken?
• It is given as a solution in your vein through your IV.
• Are there any precautions when prescribed this medication?
• Tell your healthcare provider:
o The names of all medications you are currently taking. This medication may
not mix well with other medications.
o If you are pregnant or plan to get pregnant.
o If you are breast feeding.
o If you have gallbladder disease.
o If you have kidney disease.
o If you have an allergy to penicillin.
• Avoid beer, wine, or mixed drinks.
What are some side effects of this medication?
• Irritation at the IV site.
• Fatigue.
• Fever.
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• Nausea, vomiting, diarrhea.
• Thrush (fungal infection in the mouth).
• For women, vaginal yeast infection. Report itching or discharge.
• Rash.
When do I need to call my healthcare provider?
• Signs of a very bad reaction to the medication: wheezing; chest tightness;
fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips,
tongue, or throat.
• Very bad belly pain or throwing up.
• Very loose stools (diarrhea) that are uncontrollable, even after medication is
stopped.
• Any rash.
Where to find additional medication information:
• Reputable websites that end in .org or .gov (https://druginfo.nlm.nih.gov
mayoclinic.org).
• Ask your nurse for the full printout from the hospital’s approved drug
resources.

References:
Adams, M., & Urban, C. Q. (2019). Pharmacology: Connections to nursing practice (4th ed.). Pearson.
Jones & Bartlett Learning. (2021). Nurse’s Drug Handbook. Twentieth Edition.
Whalen, K. (2019). Lippincott Illustrated Reviews Pharmacology. (C.Field & R. Radhakrishnan, EDS.) (Seventh). Wolters Kluwer
Woo, T. M., & Robinson, M. V. (2020). Pharmacotherapeutics for Advanced Practice Nurse Prescribers (Fifth). F.A. Davis Company.
6/26/22 kp
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TEACH-BACK APPROACH FOR CLINICIAN
1.Use simple terms to explain or demonstrate 2. Check understanding.: Ask the patient to repeat back in their own
words. 3. Clarify: Identify and re-explain any misunderstandings. 4. Re-check and re-clarify: Repeat steps 2-3 until
no misunderstandings. 5. Close the loop. Once all misunderstandings are clarified, ask the patient to repeat
everything in their own
words.

Vancomycin (Vancocin™) Glycopeptide antibiotic
Dosage:
Diagnosis:
• Please use this sheet to help you to know facts about your medications. It adds to
instructions from your healthcare provider and nurse. You may or may not go
home on this medication.
What is this medication used for?
It stops or treats bacterial infections.
How does this medication work?
• Vancomycin works to kill bacteria and fight infection.
How is this medication best taken?
• It is given as a solution in your vein through your IV.
Are there any precautions when prescribed this medication?
• Tell your healthcare provider:
o The names of all medications you are currently taking. This medication
may not mix well with other medications.
o If you are pregnant or plan to get pregnant.
o If you are breast-feeding.
• May increase the risk of lactic acid build up when administered with
metformin (Glucophage™), especially in patients with KIDNEY PROBLEMS.
• Medications that also affect kidneys: aminoglycosides (Gentamicin™ or
Tobramycin™), piperacillin-tazobactam (Zosyn™), and furosemide (Lasix™)
should be avoided if possible.
• Irritation of the vein or IV site if given through IV.
What are some side effects of this medication?
• Reddening of your cheeks.
• Low blood pressure.
95

• Fast heart rate.
• Headache.
• Hearing loss.
• Nausea, vomiting, diarrhea, or belly pain
• Stomach pain.
• Clostridium difficile (C. diff.).
• Urinary tract infection.
• Acute kidney injury.
• Rash on upper body.
• Anemia.
When do I need to call my healthcare provider?
• Signs of a very bad reaction to the drug: wheezing; chest tightness; fever;
itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or
throat.
• Very loose stools (diarrhea) that are uncontrollable, even after doses are
complete.
• Very bad skin irritation.
• During the IV infusion, a rash on the face, neck, trunk, and arms.
• Big change in balance.
• If no improvement occurs after a few days.
• Ringing in ears or change in hearing.
• Cannot urinate.
• Take all the medication ordered, even if you start to feel better.
Where to find additional medication information:
• Reputable websites that end in .org or .gov (https://druginfo.nlm.nih.gov
mayoclinic.org)
• Ask your nurse for the full printout from the hospital’s drug resources.

References:
Adams, M., & Urban, C. Q. (2019). Pharmacology: Connections to nursing practice (4th ed.). Pearson.
Jones & Bartlett Learning. (2021). Nurse’s Drug Handbook. Twentieth Edition.
Whalen, K. (2019). Lippincott Illustrated Reviews Pharmacology. (C.Field & R. Radhakrishnan, EDS.) (Seventh). Wolters Kluwer
Woo, T. M., & Robinson, M. V. (2020). Pharmacotherapeutics for Advanced Practice Nurse Prescribers (Fifth). F.A. Davis Company.
6/26/22 kp
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TEACH-BACK APPROACH FOR CLINICIAN
1.Use simple terms to explain or demonstrate 2. Check understanding.: Ask the patient to repeat back in their own
words. 3. Clarify: Identify and re-explain any misunderstandings. 4. Re-check and re-clarify: Repeat steps 2-3 until
no misunderstandings. 5. Close the loop. Once all misunderstandings are clarified, ask the patient to repeat
everything in their own words.

Piperacillin/Tazobactam (Zosyn™) Penicillin extended spectrum
Dosage:
Diagnosis:
• Please use this sheet to help you to know facts about your medications. It adds to
instructions from your healthcare provider and nurse. You may or may not go
home on this medication.
What is this medication used for?
• It treats bacterial infections.
How does this medication work?
• Piperacillin and tazobactam work together like partners. The piperacillin kills
the bacteria. The tazobactam protects the piperacillin so that it can work to
fight the bacteria.
How is this medication best taken?
• It is given as a solution in your vein through your IV.
Are there any precautions when prescribed this medication?
• Tell your healthcare provider:
o The names of all medications you are currently taking. This medication
may not mix well with other medications.
o If you have kidney disease.
o If you are pregnant or plan to get pregnant.
o If you are breast feeding.
o Your potassium levels may become too high or too low if you take a
diuretic medication.
• Avoid beer, wine, or mixed drinks.
• Birth control may not work as well, so make sure you use other types of
protection
What are some side effects of this medication?
• Nausea, vomiting, diarrhea, or belly pain.
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Headache.
• For women, vaginal yeast infection. Report itching or discharge.
When do I need to call my healthcare provider?
• Signs of a very bad reaction to the drug: wheezing; chest tightness; fever;
itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or
throat.
• Very bad belly pain or throwing up.
• Very loose stools (diarrhea) that are uncontrollable, even after medication is
stopped.
• Any rash.
Where to find additional medication information:
• Reputable websites that end in .org or .gov (https://druginfo.nlm.nih.gov
mayoclinic.org)
• Ask your nurse for the full printout from the hospital’s drug resources.
•

References:
Adams, M., & Urban, C. Q. (2019). Pharmacology: Connections to nursing practice (4th ed.). Pearson.
Jones & Bartlett Learning. (2021). Nurse’s Drug Handbook. Twentieth Edition.
Whalen, K. (2019). Lippincott Illustrated Reviews Pharmacology. (C.Field & R. Radhakrishnan, EDS.) (Seventh). Wolters Kluwer
Woo, T. M., & Robinson, M. V. (2020). Pharmacotherapeutics for Advanced Practice Nurse Prescribers (Fifth). F.A. Davis Company.
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TEACH-BACK APPROACH FOR CLINICIAN
1.Use simple terms to explain or demonstrate 2. Check understanding.: Ask the patient to repeat back in their own
words. 3. Clarify: Identify and re-explain any misunderstandings. 4. Re-check and re-clarify: Repeat steps 2-3 until
no misunderstandings. 5. Close the loop. Once all misunderstandings are clarified, ask the patient to repeat
everything in their own words.

Hydromorphone (Dilaudid™) Opioid analgesic
Dosage:
Diagnosis:
• Please use this sheet to help you to know facts about your medications. It adds to
instructions from your healthcare provider and nurse. You may or may not go
home on this medication.
What is this medication used for?
• It is used to ease or relieve pain.
How does this medication work?
• Hydromorphone decreases the feeling of pain and how people react to pain.
How is this medication best taken?
• It is given as a solution in your vein through your IV.
Are there any precautions when prescribed this medication?
• Talk with your healthcare provider:
o If you have a history of a medication or drinking problem.
o If you are taking a selective serotonin reuptake inhibitor (SSRI) or a
tricyclic antidepressant, it may increase risk of serotonin syndrome.
o If you have seizures.
o If you have liver disease.
o About all medications you are taking, this medication may not mix well
with some other medications.
o If you are pregnant or plan on getting pregnant.
• If you have been taking this medication for many weeks, you may want to
slowly stop this medication.
• This medication may be habit-forming with long-term use.
What are some side effects of this medication?
• Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking
clearly.
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Avoid driving and doing other tasks or actions that call for you to be alert or
have clear eyesight until you see how this medication affects you.
• May cause a decrease in blood pressure, palpitations, fast heartbeat.
• Feeling dizzy: stand up slowly over a few minutes when sitting or lying down.
Be careful climbing.
• Upset stomach or throwing up, diarrhea.
• Hard stools (constipation). Drinking more liquids, working out, or adding fiber
to your diet may help. Talk with your healthcare provider about a stool
softener or laxative.
When do I need to call my healthcare provider?
• If you think you had an overdose, call your local poison control center, or go to
an Emergency Room right away.
• Signs of a very bad reaction to the medication: wheezing; chest tightness;
fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips,
tongue, or throat.
Where to find additional medication information:
• Reputable websites that end in .org or .gov (https://druginfo.nlm.nih.gov
mayoclinic.org)
• Ask your nurse for the full printout from the hospital’s drug resources.
•

References:
Adams, M., & Urban, C. Q. (2019). Pharmacology: Connections to nursing practice (4th ed.). Pearson.
Jones & Bartlett Learning. (2021). Nurse’s Drug Handbook. Twentieth Edition.
Whalen, K. (2019). Lippincott Illustrated Reviews Pharmacology. (C.Field & R. Radhakrishnan, EDS.) (Seventh). Wolters Kluwer
Woo, T. M., & Robinson, M. V. (2020). Pharmacotherapeutics for Advanced Practice Nurse Prescribers (Fifth). F.A. Davis Company.
6/26/22 kp

100

TEACH-BACK APPROACH FOR CLINICIAN
1.Use simple terms to explain or demonstrate 2. Check understanding.: Ask the patient to repeat back in their own
words. 3. Clarify: Identify and re-explain any misunderstandings. 4. Re-check and re-clarify: Repeat steps 2-3 until
no misunderstandings. 5. Close the loop. Once all misunderstandings are clarified, ask the patient to repeat
everything in their own words.

Calciparine (Heparin™) Indirect thrombin inhibitor
Dosage:
Diagnosis:
• Please use this sheet to help you to know facts about your medications. It adds to
instructions from your physician and nurse. You may or may not go home on this
medication.
What is this medication used for?
• It thins the blood so that clots will not form.
How does this medication work?
• Heparin changes the body's clotting system. It thins the blood to stop clots from
forming.
How is this medication best taken?
• It is injected into the skin, usually around the area of the belly button.
• Wash your hands before and after use.
• Rotate among the sites where you give the injection.
• Throw away needles in a needle/sharp disposal box and take the box back to your
healthcare provider when it is full.
Are there any precautions when prescribed this medication?
• Talk with your healthcare provider:
• Before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo,
ibuprofen or like products, pain medications, or vitamin E.
• If you are pregnant or plan on getting pregnant.
• If you are breast feeding.
• Tell dentists, surgeons, and other healthcare providers that you are taking this
medication.
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You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and
an electric razor.
• Be careful to stop injuries and avoid falls.
What are some side effects of this medication?
• Bleeding problems.
• Irritation where the injection is given.
• May cause weak bones with long-term use.
When do I need to call my healthcare provider?
• Signs of a very bad reaction to the medication: wheezing; chest tightness; fever;
itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or
throat.
• A fall when you hit your head. Talk with your healthcare provider even if you feel
fine.
• Swelling or pain in the leg or arm.
• Any rash.
Where to find additional medication information:
• Reputable websites that end in .org or .gov (https://druginfo.nlm.nih.gov
mayoclinic.org).
• Ask your nurse for the full printout from the hospital’s drug resources.
•
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